Eur Spine J DOI 10.1007/s00586-015-3886-1

REVIEW ARTICLE

MIS lateral spine surgery: a systematic literature review of complications, outcomes, and economics Jeff A. Lehmen1 • Edward J. Gerber1

Received: 9 March 2015 / Revised: 18 March 2015 / Accepted: 19 March 2015  Springer-Verlag Berlin Heidelberg 2015

Abstract Background Over the past decade, the minimally disruptive lateral transpsoas approach for lumbar interbody fusion (MI-LIF) is increasingly being used as an alternative to conventional surgical approaches. The purpose of this review was to evaluate four primary questions as they relate to MI-LIF: (1) Is there an anatomical justification for MI-LIF at L4–5? (2) What are the complication and outcome profiles of MI-LIF and are they acceptable with respect to conventional approaches? (3) Given technical and neuromonitoring differences between various MI-LIF procedures, are there any published clinical differences? And, (4) are modern minimally disruptive procedures (e.g., MI-LIF) economically viable? Methods Through a MEDLINE and Google Scholar search, a total of 237 articles that discussed MI-LIF were identified. Of those, topical areas included anatomy (22), biomechanics/testing (17), technical descriptions (11), case reports (40), complications (30), clinical and radiographic outcomes (43), deformity (23), trauma or thoracic applications (10), and review articles (41). Results In answer to the questions posed, (1) there is a high strength of evidence showing MI-LIF to be anatomically justified at all levels of the lumbar spine from L1–2 to L4–5. The evidence also supports the use of advanced neuromonitoring modalities. (2) There is moderate strength evidence in support of reproducible and reasonable complication, side effect, and outcome profiles following MI-LIF which may be technique dependent. (3) & Jeff A. Lehmen [email protected] 1

Spine Midwest, Inc., 200 St. Mary’s Plaza, Suite 301, Jefferson City, MO 65101, USA

There is low-strength evidence that shows elevated neural complication rates in non-traditional (e.g., shallow-docking approaches and/or those without specialized neuromonitoring) MI-LIF, and (4) there is low- to moderatestrength evidence that modern minimally disruptive surgical approaches are cost-effective. Conclusions There is considerable published evidence to support MI-LIF in spinal fusion and advanced applications, though the results of some reports, especially concerning complications, vary greatly depending on technique and instrumentation used. Additional cost-effectiveness analyses would assist in fully understanding the long-term implications of MI-LIF. Keywords XLIF  DLIF  Literature review  Complications  Outcomes

Introduction The minimally disruptive lateral transpsoas approach to the lumbar spine for interbody fusion (MI-LIF) was developed in the late 1990s and early 2000s by Luiz Pimenta [1] and was first published in the literature in 2006 as extreme lateral interbody fusion (XLIF, NuVasive, Inc. San Diego, CA) [2]. The approach was developed as an alternative to both anterior and posterior interbody access channels, obviating the need for an access surgeon and vascular/visceral retraction compared to anterior approaches [3–6] and without bony dissection, muscular denervation, and elevated infection risks of posterior approaches [7, 8]. The MI-LIF approach allows for a thorough discectomy from the lateral border of the anterior spine through an approximately 90 off midline, retroperitoneal, transpsoas corridor, which leaves the anterior and posterior

123

Eur Spine J

longitudinal ligaments (A/PLL) intact. This is followed by placement of a large-aperture interbody spacer (similar to an anterior lumbar interbody fusion (ALIF) spacer) which spans the cortical bone of the ring apophysis. Various supplemental internal fixation options can be used for fixation without patient repositioning, including lateral plating, unilateral pedicle screws, bilateral transpedicular facet screws, spinous process plating, and, in certain circumstances, bilateral pedicle screws. Anatomically, passage to the lateral disc space through the psoas muscle requires blunt dissection into the retroperitoneal space to the lateral border of the psoas muscle, and then guided passage through the psoas muscle adjacent to the lumbar plexus. As such, advanced neuromonitoring techniques are recommended to monitor the approach to the disc space with respect to the location of neural anatomy. The MI-LIF procedure can generally be used cranially to the T4–5 level (restricted by the scapula) and caudally to L4–5 (restricted by the position of the iliac crest), though in some instances L5–S1 is accessible with a lateral approach. Since the development of XLIF, several other lateral approach instrumentation have been developed, including direct lateral interbody fusion (DLIF, Medtronic Sofamor Danek, Memphis, TN), lateral lumbar interbody fusion (LLIF, Globus Medical, Inc. Audubon, PA), the VEO system [9] (Baxano Surgical, Inc. Raleigh, NC, USA), MIS lateral system (DepuySynthes, Inc. Raynham, MA), and non-retracted transpsoas approaches (shallow docking) [10].While broad similarities exist between these MI-LIF approaches, there are some important differences between platforms, most notably the recommended use of neurophysiologic monitoring (e.g., automated [2], interpretative (technician), or none [9]). Therefore, this report will use the term MI-LIF to generically refer to lateral transpsoas approaches and will refer to specific transpsoas platforms only in describing individual articles that make the differentiation. There are several aspects of the MI-LIF procedure which have been studied extensively, and a few smaller literature reviews, but there has yet to be a broad literature review covering multiple topical areas, which precipitates the current work. The areas covered in this review include anatomical understandings of the lateral approach, safety and outcome profiles, different lateral approach-type comparisons, and economics. The purpose of this review was to evaluate four primary questions as they relate to MILIF: (1) Is there an anatomical justification for MI-LIF at L4–5? (2) What are the complication and outcome profiles of MI-LIF and are they acceptable with respect to conventional approaches? (3) Given technical and neuromonitoring differences between various MI-LIF procedures, are there any published clinical differences? And, (4) are modern minimally disruptive procedures (e.g., MI-LIF) economically viable?

123

Methods A search of peer-reviewed, human-subject journals through MEDLINE and Google Scholar databases from 1995 to February 27th, 2015 was conducted using search terms including ‘‘extreme,’’ ‘‘lateral,’’ ‘‘direct,’’ ‘‘transpsoas,’’ ‘‘XLIF,’’ ‘‘DLIF,’’ and/or ‘‘LLIF,’’ and ‘‘lumbar,’’ ‘‘fusion,’’ ‘‘spin*,’’ without ‘‘(citation),’’ ‘‘posterolateral’’ or ‘‘cervical.’’ Any full-length article that described MI-LIF was included in the current study in an attempt to collect all currently available peer-reviewed articles. Each article from the primary search was assessed individually across titles and abstract for inclusion within the previously described parameters. A secondary review which included full article review was undertaken to further discriminate the primary findings. The authors attempted to pool outcome variables where reasonable homogeneity in patient population and technique were apparent. Study design, level of evidence, and sample size (including weighting) were similarly considered. A qualitative analysis was performed for the answer to each question posed with respect to the available literature across three domains including quality, quantity, and consistency of support for the answer [11]. From there, ratings of high, moderate, low, and very low were assigned to the conclusion from each question (by author JAL), based on guidelines from the GRADE working group [12]. High strength of conclusions are made based on literature that has quality (level of evidence [13] I–III findings, depending on study type and conclusions drawn), quantity, and consistency in support of the conclusion drawn. Further research in areas of high recommendation would have a low likelihood of changing findings. Moderate conclusions always come from quality findings, though may lack either consistency or quantity, but not both. The confidence in such conclusions has the potential to be changed by additional, higher quality research. Low-strength research conclusions lack quality, but have both consistency and quantity or they lack quantity and consistency but have quality. These findings are likely to have their confidence altered by additional, high-quality research. Finally, very low quality conclusions lack all three areas or have just quantity or consistent findings, without quality. For these conclusions, effect estimates are very uncertain [14].

Results A total of 2910 articles were identified through the primary search. Following adjudication, 237 articles were determined to meet inclusion in the current review (Fig. 1). Distribution of evidence quality (levels of evidence [13]) of the lateral-approach specific articles included 27 Level 1

Eur Spine J

studies (of which 26 were non-clinical), 3 Level 2 studies, 30 Level 3 studies, 155 Level 4 studies, and 22 Level 5 studies. Of these 237 articles, 22 were MI-LIF-specific studies of lateral anatomy relevant to the surgical approach [15–36], 17 were biomechanical or non-interventional testing studies [37–53], 11 technical descriptions [2, 9, 10, 54–61], 40 case reports [62–101], 30 reports specifically examining complications [102–131], 43 studies assess clinical and/or radiographic outcomes in degenerative conditions [132–174], 23 specifically examining treatment and outcomes of deformity with MI-LIF [175–198], 10 articles reviewing traumatic or thoracic indications[218– 227], and 41 review articles without original data [198– 217, 228–248].

In order to more succinctly review the evidence, each question posed will be addressed separately. Question 1: Is there an anatomical justification for MI-LIF, particularly at the L4–5 level? A summary of results from anatomical studies specific to MI-LIF are included in Tables 1 and 2. There is a large number (quantity) of high-quality articles reporting similar findings (consistency) that support a high strength conclusion that there is anatomical justification for the MI-LIF approach at all lumbar levels from L1–2 to L4–5. In these studies, all authors found at least the anterior half of the lateral disc space consistently free of neural trunks and

Fig. 1 Flow diagram of systematic review. MI-LIF minimally disruptive lateral interbody fusion, TDR total disc replacement

123

Eur Spine J

roots. Articles that reported absolute measurements found between 22 and 31 mm of the lateral surface of the disc space anterior to the plexus free of motor nerves from L1–2 through L4–5 [25], and between 72 and 78 % of the lateral disc space free of motor nerves at L4–5 [16, 23, 28]. Question 1—representative articles Park et al. [27] studied 40 levels from L1–2 to L4–5 in 10 cadavers to assess the average absolute distance from the midpoint of the lateral disc space posteriorly to the anterior border of the lumbar plexus (trunk) and to the nerve roots. At L2–3, L3–4, and L4–5, the authors found, on average, 16.4, 14.9, and 10.6 mm of distance between the lateral midpoints of the discs to the nerve trunk. In all cases the nerve roots were dorsal to the trunks. Where lateral intervertebral cages range anywhere from 18 to 26 mm wide (anterior-posterior dimension) these results suggest that there is adequate space for cage placement anterior to the lumbar plexus at levels from L1–2 to L4–5 without requiring neural retraction (assuming the cage will occupy both the available space posterior to the lateral midline as well as the anterior half of the disc space). Another study by Benglis et al. [16] studied three cadavers at 12 levels from L1–2 through L4–5 to assess the distance from the posterior border of the lateral disc space to the anterior border of the lumbar plexus and calculated this as a percentage of the entire lateral disc space (100 %). At L1–2, L2–3, L3–4, and L4–5, the authors found, on average, the posterior 0, 11, 18, and 28 % of the lateral disc space was obstructed by the lumbar plexus, resulting in 100, 89, 82, and 72 % of the anterior portion of the lateral disc space free of motor nerves, at the respective levels. These data are closely corroborated in a study by Regev et al. [28] where similar measurements were made using 100 subjects (247 levels) on magnetic resonance imaging (MRI) and 89, 84, 84, and 74 % of the anterior disc space was found to be free of motor nerves (approximated by assessing the neural-adipose complex on the lateral posterior border of the disc space on axial MRI), using a 95 % confidence interval. Question 2: What are the safety (complication) and outcome profiles of MI-LIF and are they acceptable in comparison with conventional approaches? Safety There is considerable variation in the literature concerning reported rates of complication following MI-LIF [165, 229, 231]. As there are significant differences in indications for use, patient sample characteristics, levels treated,

123

supplemental fixation used, techniques (XLIF vs. DLIF vs. other lateral) and neuromonitoring used (automated vs. technician), and terminology and classification of complications used, making unqualified conclusions about the safety of the approach becomes very challenging. The highest quality data available reports an overall perioperative complication rate of 5 % in the treatment of basic degenerative conditions with XLIF, including a 2.9 % rate of motor nerve injury [120]. This overall rate of complication and neural injury rate are corroborated by several studies that have similar inclusion criteria [102, 109, 118, 135, 136, 165]. Complication and side effect outliers tend to be in mixed indication samples (degenerative and deformity) with mixed procedures being performed (XLIF or DLIF or other lateral) [103, 151, 177, 187]. Several studies compared MI-LIF directly to conventional approaches and all showed significantly more favorable complication profiles for MI-LIF compared to conventional approaches [111, 117, 160]. Several studies also found that there were no incremental increases in morbidity treating patients predisposed to complications (elderly, obese) with MI-LIF [116, 117, 249]. In making a conclusion, high-quality evidence exists to support the safety of the MI-LIF approach with a large quantity of reports. However, there is a lack of consistency between reports, the reasons for which are multifactorial. This leads to a moderate-strength conclusion confirming that the MI-LIF approach is acceptable from a morbidity standpoint within the context of currently available approaches. A table of complication literature is included in Table 3. Question 2—safety—representative articles Several articles directly examine perioperative complications of MI-LIF. As previously mentioned, the highestquality evidence is from a prospective, multi-center, IRBapproved study of neural and general complications following XLIF at L3–4 and/or L4–5 by Tohmeh et al. [120]. In this study, 102 patients were treated with XLIF using the NV JJBTM/M5 (NuVasive, Inc.) neuromonitoring platform and were followed through the perioperative period to assess any postoperative complications or side effects and their resolution. Two (2 %) intraoperative complications were observed, both minor perforations of the peritoneum which did not require repair and which resolved without sequelae. Hip flexion weakness postoperatively was common (27.5 %), was considered to be a side effect of the approach, and was thought to be due to direct trauma to the psoas muscle during access to the lateral disc space and retraction during the procedure. The magnitude of weakness (most commonly Medical Research Council grade 4/5) and resolution (all in the early postoperative period) suggested muscular, rather than neural trauma, as the

I

I

I

I

I

I

I

I

I

I

I

I

I

Moro et al. [250]*

Park et al. [27]

Regev et al. [28]

Uribe et al. [31]

Davis et al. [19]

Benglis et al. [16]

Hu et al. [24]

Kepler et al. [25]

Guerin et al. [22]

Guerin et al. [23]

Lu et al. [26]

Yusof et al. [36]

Yusof et al. [36]

100

100

15

8

78

43

48

3

18

5

100

10

30

Subjects

200

200

120

60

304

172

192

12

54

20

247

40

120

Levels

In vivo

In vivo

Cadaver

Cadaver

In vivo

In vivo

In vivo

Cadaver

Cadaver

Cadaver

In vivo

Cadaver

Cadaver

Specimen

Degenerative

Degenerative

Normal

Normal

Normal

Normal

Normal

Normal

Normal

Normal

Normal

Normal

Normal

Population

MRI (mm)

MRI (mm)

Direct (zones)

Direct (zones)

MRI (%)

MRI (mm)

MRI (zones)

Direct (%)

Direct (zones)

Direct (mm)

MRI (95 % CI)

Direct (mm)

Direct (zones)

Measurement

mm from right-side anterior VB to plexus

mm from left-side anterior VB to plexus

Zones in thirds, plexus

I–IV safe zones, motor nerves

% of disc space from posterior border

mm from anterior VB to plexus

I–IV safe zones, nerves

% of disc space from posterior border

I–IV safe zones, motor nerves

I–IV safe zones, motor nerves

% of disc space from posterior border

Plexus distance from disc center

I–IV safe zones, nerves

Measurement definition

* Moro et al. included for historical reference

L4–5

L5–S1









11.1 %

30.8



0%





10.6 %













18.7 %

28.6



11 %





15.5 %

16.4



29.0

28.6





21.9 %

28.2



18 %





16.4 %

14.9



23.1

22.6





35.8 %

22.1



28 %





25.9 %

10.6























49.0 %









I–II

I–III

I–III



I–IV

I–IV



I–III

I–III









I–II

I–III

I–III



I–III

I–III



I–III

I–III



I–III

L2–3





I–II

I–III

I–III



I–II

I–III



I–III

I–III



I–II

L3–4





I–II

I–II

I–II



I–II

I–II

I–II

I–II

I–II



I–II

L4–5





















I–II



None

L5–S1

L1–2

L3–4

L1–2

L2–3

Converted motor nerve safe zones

Motor nerve location

LOE level of evidence (I–V) [11], mm millimeters, MRI magnetic resonance imaging, CI confidence interval, VB vertebral body

LOE

References

Table 1 Summary of quantitative anatomical studies specific to MI-LIF

Eur Spine J

123

123

IV

I

IV

IV

IV

IV

I

IV

IV

I

I

Dakwar et al. [17]

Banagan et al. [15]

Dakwar et al. [18]

Baaj et al. [33]

Menezes et al. [34]

Delasotta et al. [20]

Deukmedjian et al. [21]

Shirzadi et al. [29]

Voyadzis et al. [35]

Smith et al. [30]

Smith et al. [30]





3

1

10

1

94

5

9

8

6

Subjects





3

1

80

1

188

5 sides

18 sides

64

12 sides

Levels

Review

Review

In vivo

In vivo

In vivo

In vivo

In vivo

Cadaver

Cadaver

Cadaver

Cadaver

Specimen



Normal

Irregular

Irregular

Normal

Irregular

Normal

Normal

Normal

Normal

Normal

Population

Zone extrapolation

MRI and CR psoas muscle findings

MRI psoas muscle findings

L5–S1 lateral approach feasibility

Anatomy position in lateral decubitus

Variant vascular anatomy description

MRI % of nerves in zones by retractors

Anatomical description

Anatomical description

Sympathetic chain from ALL

Anatomical description

Measurement definition

351 series sample showing a 2.8 % transitional anatomy (and related difficulty in lateral approach) rate Found broad consistency between studies justifying MI-LIF from an anatomical perspective

Found that a ‘‘rising’’ psoas indicated a more difficult passage to the lateral disc space under neuromonitoring

Case description of potential for L5–S1 lateral approach

Vasculature travel significantly anteriorly from the lateral approach corridor in the lateral decubitus position.

Presentation of aberrant iliac artery case

Virtual overlay of 10 mm and 22 mm retractors to show interference with nerves based on retractor size

Describes attachments of diaphragm and considerations for deflection for lateral TLJ approaches

Describes attachments of diaphragm and considerations for deflection for lateral TLJ approaches

Sympathetic chain and average of 9.25 mm posterior from ALL; 25 % of k-wires pierced nerves

Describes origin and paths of subcostal, iliohypogastric, ilioinguinal, and lateral femoral cutaneous nerves

Summary

LOE level of evidence (I–V) [11], ALL anterior longitudinal ligament, TLJ thoracolumbar junction, MI-LIF minimally disruptive lateral interbody fusion

LOE

Author

Table 2 Summary of qualitative anatomical studies specific to MI-LIF

Eur Spine J

XLIF

XLIF

Hyde and Seits [137]

Johnson et al. [138]

XLIF 22 mm wide

XLIF/cougar/SD

XLIF

XLIF

XLIF

PLIF

Nemani et al. [129]

Rodgers et al. [116]

Rodgers et al. [116]

Rodgers et al. [117]

Rodgers et al. [117]

Lykissas et al. [128]

Marchi et al. [113]

XLIF/cougar/SD ? auto/allograft

Lykissas [128]

XLIF/cougar/SD

XLIF/cougar/SD ? BMP

Lucio et al. [111]

XLIF 18 mm wide

Open PLIF

Lucio et al. [111]

Lykissas et al. [127]

X, TLIF

Lee et al. [110]

Marchi et al. [113]

XLIF

XLIF

Le et al. [109]

XLIF/cougar/SD

XLIF

Dakwar et al. [104]

XLIF

XLIF

Dakwar et al. [104]

Le et al. [108]

SD

Cheng et al. [124]

Kueper et al. [126]

XLIF

XLIF/cougar/SD

Al Maaieh et al. [122]

XLIF

XLIF/cougar/SD

Aichmair et al. [121]

Cheng et al. [124]

XLIF/cougar/SD

Aichmair et al. [121]

Cahill et al. [102]

DLIF

XLIF/cougar/SD

Moller et al. [114]

Aichmair [121]

X, D, AxiaLIF

X, DLIF

Cummock et al. [103]

XLIF/Cougar/SD

Pumberger et al. [115]

Knight et al. [106]

X, DLIF

XLIF, L5S1

Anand and Baron [198]

Isaacs et al. [182]

Procedure

References

III

III

III

III

IV

III

III

IV

III

III

III

III

III

IV

IV

IV

IV

IV

IV

IV

III

III

IV

III

III

III

III

III

III

III

III

II

IV

LOE

XLIF

Degen

Degen

Degen

BMI \ 30 PLIF

Degen

Degen/scoli

DDD

DDD

Degen/scoli

Degen/scoli

Degen/scoli

Degen

Degen

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

NR

Degen

Degen/scoli

Degen/scoli

Scoliosis

Scoliosis

Indication

1–8

1–3

1–4

1–4

1–4

1–2

1–2

1–5

2 pp

2 pp

2

2

1–3

1–4

1–4

1–5

1–3

1–4

1–4

3–6

1–4

1–4

1–3

2.3 pp

1–4

1–4

1–5

1.9 pp

1–3

1–3

1.9 pp

1–6

NR

Ant lvls

TL

TL

L

L

L1–5

L

L

T12–L5

T12–L5

T12–L5

L1–S1

L1–S1

L

L

L

T9–S1

L2–5

L1–5

L

TL

L1–L5

L1–L5

T12–L1

T11–L5

T12–L5

T12-L5

T12–L5

L

L2–L5

L1–L5

T12–L5

T8–S1

NR

Lvls

Treatment characteristics

BMI [ 30

18 mm

22 mm

BMP

Non-BMP

XLIF

PLIF

XLIF

SD

Control

Table 3 Summary of study characteristics and complication findings in published MI-LIF cohorts

PS

Mixed

Mixed

Mixed

None

None

None

Mixed

Mixed

Mixed

BP

BP

NR

Mixed

LP

Mixed

Mixed

Mixed

NR

NR

PS

PS

Mixed

Mixed

Mixed

Mixed

Mixed

NR

NR

PS

NR

Mixed

PS

Internal fixation

None

None

None

2

2

0–9

# of posterior levels

20

40

157

156

117

28

46

451

72

72

101

109

33

71

101

900

39

78

568

315

50

70

118

42/596

91

155

47

53

58

59

235

107

76

Total n

Periop

Periop

3 mo

3 mo

15.6 mo

12 mo

12 mo

15 mo

16.1 mo

18.5 mo

45 days

45 days

6 mo

12 mo

14.3 mo

Periop

6 mo

Periop

Periop

Periop

10 mo

10 mo

Periop

Periop

10.5 mo

16.5 mo

21.0 mo

21.2 mo

15 mo

10 mo

Periop

6 weeks

40 mo

Mean follow-up

146

81

75

298.8

291.9

156.5

163.2

221

392

297.0

257.6

265.5

161

255

178

277

ORT (min)

144

\50

\50

109.9

910.7

136

138

50–100

541

EBL (mL)

5.3

1.3

1.24

1.24

3.2

1.2

2.7

9.9

5

4.0

3.8

7.8

LOS (days)

Eur Spine J

123

123

Complications and side effects

References

10 % miscellaneous complications

2011–2012 patients. Neural deficits reported as postop %—last follow-up %. Did not distinguish between motor deficits and HFW Data reported only for the 42 (7 %) patients with postoperative ileus

Aichmair et al. [121]

Al Maaieh et al. [122]

Transient thigh column = all neurologic deficits 1.5 % complex cases w/rhabdomyolysis 1.8 % with abdominal wall paresis 10 % radiographic subsidence, 2 dehiscence, 1 DVT

Cheng et al. [124]

Dakwar et al. [104]

Dakwar et al. [104]

Hyde and Seits [137]

0.56 % (5/900) vascular injury rate, four segmentals, one abdominal aorta. All recovered. 5.9 % lateral plating related complications

Kueper et al. [126]

Le et al. [108]

Johnson et al. [138]

Transient thigh column = all neurologic deficits

Cheng et al. [124]

5.1

2009-2010 patients. Neural deficits reported as postop %—last follow-up %. Did not distinguish between motor deficits and HFW

Aichmair et al. [121]

4.2

2006–2008 patients. Neural deficits reported as postop %—last follow-up %. Did not distinguish between motor deficits and HFW

Aichmair [121]

Cahill et al. [102]

1 psoas hematoma, 1 segmental artery laceration

Moller et al. [114]

8.6

19.8

12.8

33

24.0

14.2

25.0–6.6

43.4–11.0

44.4–14.9

25

8.6

42.4

Knight et al. [106]

13.8

NR

Mixed

PS

Internal fixation

# of posterior levels

Transient/thigh sensory symptoms (%)

L3–4 and/or L4–5

L

L

Lvls

Cummock et al. [103]

12.1

1–2

1–4

1–4

Ant lvls

ORT and EBL for single stage surgeries only. LOS includes staged surgeries

Degen/scoli

Degen/scoli

Degen

Indication

Treatment characteristics

28.7

15.9

II

Control

Pumberger et al. [115]

Isaacs et al. [182]

Anand and Baron [198]

XLIF

Tohmeh et al. [120]

IV

IV

LOE

Other/comment (%)

XLIF/cougar/SD

Major (%)

XLIF

Rodgers et al. [118]

Taher et al. [130]

Minor (%)

Procedure

References

Table 3 continued

36

19.3–2.2

24.3–2.6

22.2–4.3

36

23.7

13.1

268.8

5.1

1.7

0

6.8

4.9 1.7

LOS (days)

28.0

24.3

22.4

24.3

Total comps (%)

EBL (mL)

Reops (%)

ORT (min)

Motor neural (%)

Periop

Periop

12 mo

Mean follow-up

HFW (%)

102

244

600

Total n

Eur Spine J

45.8–40.3

19.7

Transient/thigh sensory symptoms (%)

51.4–48.6

54.9

HFW (%)

0.7

1.3

Motor neural (%)

Reops (%)

Total comps (%)

2.9 2.9

LOE level of evidence (I–V)[11], ant anterior, Lvls levels, ORT operating room time, EBL estimated blood loss, LOS length of hospital stay, Reops reoperations, Comps complications, VAS visual analog scale, ODI Oswestry disability index, XLIF extreme lateral interbody fusion, DLIF direct lateral interbody fusion, SD possible shallow docking technique used, Scoli degenerative scoliosis, BPS bilateral pedicle screws, mo months, LP anterolateral plates, PLF posterolateral fusion, TLIF minimally invasive transforaminal interbody fusion, Degen mixed degenerative conditions (e.g., spondylolisthesis, DDD, adjacent segment disease, etc…), DDD degenerative disc disease, PLIF open posterior interbody fusion, sig significantly, BMI body mass index, yrs years, PS pedicle screws (uni- or bi-lateral); ASD, adjacent segment disease. Studies listed in adjacent rows with a border indicate two cohorts from the same study

Tohmeh et al. [120]

27.5

60 6.2

Rodgers et al. [118]

Taher et al. [130]

7.5

Rodgers et al. [117] 1.8

6.4 10.8

Rodgers et al. [117]

1.9

17.6

17.4 10.7

Rodgers et al. [116]

Assessed contralateral motor deficits

8.7 10.7

23.9–3.2

10.1

52 % any grade of subsidence 24 % any grade of subsidence

Marchi et al. [113]

Marchi et al. [113]

38–9.3

38.9–23.6

0.6

Neural deficits reported as postop %—last follow-up %. Did not distinguish between motor deficits and HFW

Lykissas et al. [127]

48.6–27.8

Nemani et al. [129]

Autograft/allograft patients. Neural deficits reported as postop %— last follow-up %. Did not distinguish between motor deficits and HFW

Lykissas et al. [128]

Rodgers et al. [116]

BMP patients. Neural deficits reported as postop %—last follow-up %. Did not distinguish between motor deficits and HFW.

Lykissas [128]

6

Hip flexion strength was less on the operative side, mostly resolved by 2 weeks postoperative

Other/comment (%)

14

Major (%)

Lucio et al. [111]

2

Minor (%)

Complications and side effects

Lucio et al. [111]

Lee et al. [110]

Le et al. [109]

References

Table 3 continued

Eur Spine J

123

Eur Spine J

cause. New upper medial thigh sensory loss was noted in 17.6 % of patients, most commonly a grade of 1/2 and, similar to hip flexion weakness, all resolved in the study within the perioperative period. Three (2.9 %) new distal motor deficits were observed: one 4/5 grade tibialis anterior deficit which resolved by 6 months, one 3/5 grade quadriceps weakness which resolved by 6 months, and one 4/5 grade quadriceps weakness which resolved by 6 weeks postoperatively. While this report highlights resolution of these deficits, other reports have shown continuing deficits (motor and sensor) at longer follow-up ([12 months), so any implication of non-permanence in all cases is not made [103]. A second study from prospectively collected registry data by Rodgers et al. [118] found a 6.2 % overall complication rate in 600 consecutive XLIF patients through 6 weeks postoperative. This rate included a 4.3 % rate of in-hospital complications (surgical and medical), 0.7 % rate of new distal motor deficits, and 1.8 % reoperation rate. Similar to the Tohmeh et al. [120] paper, hip flexion weakness and mild upper medial thigh sensory loss were common, but considered side effects of the approach. If sensory changes were severe or persistent, they we classified as complications. Outcomes Many reports (quantity) provide clinical and radiographic outcome information concerning MI-LIF, including several 2-year or longer follow up [132–175]. When separating outcomes by indication (degenerative vs. deformity), there is general consistency within the groups when considering some heterogeneity in specific treatment paradigms (types of fixation used, baseline patient characteristics), though some inconsistency remains in the magnitude of clinical improvement in some papers [151, 177]. There are several examples of higher quality evidence papers, with comparative groups and/or high compliance in long-term follow-up, in support of favorable long-term outcomes [143, 151–153, 156, 160]. With this in mind, the lack of consistency in the literature provides support for only a moderate-strength conclusion to be made that outcomes following MI-LIF are well documented and at least equivalent to those found in conventional procedures [160]. Reports of outcomes of individual cohorts from the literature review are reported in Table 4. Question 2—outcomes—representative articles In a prospective study by Kotwal et al. [143] 141 consecutive patients underwent MI-LIF (95 % XLIF), for a variety of degenerative conditions, including scoliosis, and 84 % (118) were available for 2-year follow-up and

123

included in the analysis. Mean patient age was 62.1 years, 59 % were females, and mean body mass index (BMI) was 27.6 kg/m2. In 118 patients, 237 levels were treated (mean 2.0 per patient). Four patients exhibited postoperative ileus, pulmonary insufficiency in two, arrhythmia in two, gastric ulcer in one, urinary retention in one, and delayed wound healing in one, all of which were treated conservatively to resolution. This resulted in a 9.3 % complication rate. Anterior thigh pain was observed in 36 % of patients, with 17 % experiencing hip flexion weakness and 11 % experiencing anterior thigh numbness. All resolved except for one patient with persistent anterior thigh pain at the last follow-up. Three patients were revised for pseudoarthrosis and one for adjacent segment degeneration (3.3 % reoperation rate through 2-year postoperative). In these 141 patients, mean postoperative follow up was 27.5 months. At last follow up, compared to baseline, pain improved and average of 53 % (8.7–4.1), disability improved 43 % (from 30.0 to 17.1), and quality of life (SF-12) physical component summary (PCS) improved 41 % from 27.0 to 38.1. Cobb angle from preoperative to last follow-up improved from 24.8 to 13.6. All comparisons from baseline were statistically significantly improved. Similar findings were reported by Rodgers et al. [153] in a study of 238 patients who underwent XLIF and who were followed for 2 years postoperatively. The authors found an average postoperative hemoglobin change of -1.4 g and a mean hospital stay of 1.2 days. Complications occurred in 6.7 % of patients, including 36 secondary reoperations or additional spine procedures. From preoperative to last follow-up, disc height increased from 6.2 to 9.0 mm, listheses were improved from 4.7 to 0.9 mm, pain improved 63 % from 8.6 to 3.2, and modified Lenke fusion assessments found an average value of 1.1 (fusion classified as either a 1 or 2), with 89.8 % of patients reaching a Lenke score of 1 and 98.9 % reaching a Lenke score of either 1 or 2. Outcome satisfaction was achieved in 87.3 % of patients and 91.4 % stated that they would still have chosen to undergo the procedure had their outcome been known in advance. Question 3: Given technical and neuromonitoring differences between various MI-LIF procedures, are there any published clinical differences? The majority of MI-LIF literature reports experience with and outcomes of XLIF (traditional lateral), as this procedure was the first developed and implemented lateral transpsoas approach for interbody fusion [2]. With the development of alternative MI-LIF approaches to the traditional lateral approach that use different transpsoas techniques and neuromonitoring [10], some early reports have emerged. In this review, there was a paucity of examples of literature strictly reviewing non-traditional

XLIF

Ahmadian et al. [133]

XLIF XLIF XLIF

Marchi et al. [147]

Marchi et al. [113]

Oliveira et al. [150] XLIF

XLIF

Marchi et al. [146]

Ozgur et al. [151]

XLIF

Malham et al. [145]

XLIF

XLIF

Le et al. [144]

Oliveira et al. [172]

XLIF XLIF

Kotwal et al. [143]

Uribe et al. [247] Kepler et al. [140]

Kepler [141]

XLIF X, TLIF XLIF

Oliveira et al. [149]

XLIF XLIF

Elowitz et al. [136]

Castellvi et al. [168]

Caputo et al. [179]

XLIF XLIF

Berjano et al. [135]

XLIF

PLF

Tormenti et al. [186]

XLIF

X, TLIF

Tormenti et al. [186]

Alimi et al. [167]

X, DLIF

Acosta et al. [132]

Ahmadian et al. [166]

XLIF/cougar/SD

Sharma et al. [159] Tempel et al. [196] X,T,PLIF

XLIF/SD XLIF w open PSF

Wang and Mummaneni [187]

Sofianos et al. [119]

X, DLIF

Khajavi and Shen [192]

Lykissas et al. [112]

XLIF XLIF

Castro et al. [190]

IV

IV

IV

III

IV

IV

III

III

IV

III

IV IV

IV

IV

IV

IV

IV

IV

IV

IV

III

III

IV

IV

IV

IV IV

IV

IV

IV

IV

X,TLIF

PLF

XLIF

Caputo et al. [189]

IV

Degen/scoli

Degen/scoli

Degen

Degen/scoli

G I/II spondy

DDD

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli

Degen/scoli Degen

Degen/scoli

Degen

Scoliosis

Degen/scoli

Degen/scoli

Degen/scoli

degen/scoli

Spondy

Scoliosis

Scoliosis

Degen/scoli

Degen/scoli

Degen

Degen/scoli Scoliosis

Scoliosis

Scoliosis

Scoliosis

Scoliosis

Scoliosis

Scoliosis

X, D, AxLIF

Anand et al. [177]

IV

X, D, AxLIF

Anand et al. [176]

1–3

1.9

1

1–2

1

1–2

1–3

1–4

1–4

2.3 pp

1–6 1

1–2

1–3

1–6

2.4 pp

1–4

1–4

1/4

1

1–3

2–5

1.8 pp

1–4

1–4 1–4

1–5

1–5

1–7

2–7

2–6

1–6

Ant lvls

Indication

Control

Procedure

References

LOE

Treatment characteristics

Study characteristics

Table 4 Summary of clinical and radiographic outcomes in published MI-LIF cohorts

T12–L5

T6–L5

L4–L5

L

L1–5

L2–5

L1–5 (T6–7)

L

L

L1–L5

T6–L5 L3–5

L

L1–L5

T10–L5

TL

T11–L5

T10–L5

T11–L5

L4–5

L2–S1

L1–L5

L1–5

L1–S1

L1–5 L1–5

T12–L5

T12–S1

TL

T10–L5

T12–S1

T12–S1

Lvls

BP

Mixed

None

None

None

None

Mixed

Mixed

Mixed

Mixed

Mixed LP

Mixed

PS

LP

BP

Mixed

Mixed

None

PS

BP

BP

PS

Mixed

NR

Mixed Mixed

BP

Mixed

None

BP

BP

BP

Internal fixation

0–5

None

None

None

None

2–7

None

4–11

6–12

None

3–7

2–8

3–8

# of posterior levels

62

14

15

46

52

22

30

140

118

29

22 13

39

25

25

44

93

90

59

31

4

8

36

45

30

43 26

23

21

35

30

12

28

Total n

24 mo

8 mo

2 yrs

12 mo

24 mo

24 mo

11.5 mo

9.6 mo

27.5 mo

6 mo

16.4 mo 6 mo

16 mo

25.6 weeks

11 mo

12 mo

12.1 mo

17.6 mo

14.6 mo

18.2 mo

11.5 mo

10.5 mo

21 mo

Periop

21 mo

12 mo 12 mo

12 mo

24 mo

24 mo

14.3 mo

22.4 mo

75 days

Mean follow-up

Eur Spine J

123

Control

123 XLIF

Rodgers et al. [154]

Rodgers et al. [155]

I

XLIF

Youssef et al. [165]

Degen/scoli

ASD

Degen

Degen/scoli

Degen Degen

G II Spondy

Degen/scoli

Degen/scoli

Degen

ASD

1

62 60.2 57.9 44.6

Tormenti et al. [186]

Tormenti et al. [186] Ahmadian et al. [133]

60

Sofianos et al. [119]

Acosta et al. [132]

47 71

Tempel et al. [196]

L

L1–5

L3–5

L1–5

L L

L2–5

L

L1–5

L

L

L1–L5

L4–5

L4–5

T8–S1

Lvls

50

43

82.1

ODI decrease (%)

38.7

51

21

1–3

1–2

1

1–3

1–2 1–2

1–3

1–4

1.1 pp

1–3

1–4

1–4

Sig Imp

Lykissas et al. [112]

100

Degen Degen

1–6 1

Sig imp

54.1

Wang and Mummaneni [187]

Sharma et al. [159]

68

32.4

57

59 100

Scoliosis Degen

VAS decrease (%)

ALIF XLIF

Khajavi and Shen [192]

88.2

100

Fusion (%)

III

IV

IV

IV

IV

BMP

SiCaP

Castro et al. [190]

Caputo et al. [189]

Anand et al. [177]

Anand et al. [176]

References

XLIF

Wang et al. [174]

IV

XLIF XLIF

Tohmeh et al. [161]

XLIF XLIF ALIF

Rodgers et al. [158]

Smith et al. [160] Smith et al. [160]

Voyadzis and Anaizi [163]

III III

XLIF

Rodgers et al. [153]

IV IV

XLIF XLIF

Rodgers et al. [156]

IV

IV

Johnson et al. [138]

Outcomes

XLIF w SiCaP XLIF

Pimenta et al. [152]

I

II

XLIF, L5S1 XLIF w BMP

Phillips et al. [185]

Pimenta et al. [152]

Ant lvls

Indication

LOE

References

Procedure

Treatment characteristics

Study characteristics

Table 4 continued

1–3

None

None

0–9

# of posterior levels

100

Outcome satisfaction (%)

Mixed

Mixed

Facet

Mixed

PS PS

PS

Mixed

Mixed

PS

Mixed

PS

None

None

Mixed

Internal fixation

82

21

10

40

115 87

63

238

50

66

100

100

15

15

82

Total n

86

Re-do (%)

15.7 mo

23.6 mo

8.2 mo

12 mo

24 mo 24 mo

12 mo

24 mo

12 mo

12 mo

6 mo

6 mo

36 mo

36 mo

24 mo

Mean follow-up

Eur Spine J

91 100

Marchi et al. [146] Marchi et al. [147]

Marchi et al. [113]

Oliveira et al. [150]

100

Pimenta et al. [152]

80

98.4 93.2

Rodgers et al. [156]

Johnson et al. [138]

Voyadzis and Anaizi [163]

Tohmeh et al. [161]

Smith et al. [160] Smith et al. [160] 90.2

90

55

68 65

62.8 75

Rodgers et al. [153]

Rodgers et al. [158]

100

67.4

Rodgers et al. [155] 41

68.7

Rodgers et al. [154]

46

46

100

Pimenta et al. [152]

37 3.4 points

Ozgur et al. [151]

Phillips et al. [185]

69

57.1

59.2

Oliveira et al. [172] 91

93 86.5

Malham et al. [145] 70 60

38.7 63

85

Le et al. [144]

89

41

60 59

35

31

31

39

56

46.9

57 55

41

39.6 52.9

57.8 43

88

47.7

Kotwal et al. [143]

100

Kepler et al. [140]

61

70.2

44.2

33

54.9

47.3

38.6

ODI decrease (%)

Kepler [141]

95.5

Uribe et al. [247]

77.5

Oliveira et al. [149]

Caputo et al. [179] 73.3

70.4

Castellvi et al. [168]

Elowitz et al. [136]

61.4 44

Berjano et al. [135] 80

45.3

VAS decrease (%)

61.5

95

Fusion (%)

Outcomes

Alimi et al. [167]

Ahmadian et al. [166]

References

Table 4 continued

92

89

89.4

85

92

95.5 % SCB

92 % success

84.8 % Macnab

Outcome satisfaction (%)

86

93

89.4

85

71

Re-do (%)

Eur Spine J

123

123

LOE level of evidence (I–V)[11], ant anterior, Lvls levels, Reops reoperations, Comps complications, VAS visual analog scale, ODI Oswestry disability index, XLIF extreme lateral interbody fusion, DLIF direct lateral interbody fusion, SD possible shallow docking technique used, Scoli degenerative scoliosis, BPS bilateral pedicle screws, mo months, LP anterolateral plates, PLF posterolateral fusion, TLIF minimally invasive transforaminal interbody fusion, Degen mixed degenerative conditions (e.g., spondylolisthesis, DDD, adjacent segment disease, etc…), DDD degenerative disc disease, PLIF open posterior interbody fusion, sig significantly, BMI body mass index, yrs years, PS pedicle screws (uni- or bi-lateral), ASD adjacent segment disease. Studies listed in adjacent rows with a border indicate two cohorts from the same study

56 61

77 100 (pts w f/u) Youssef et al. [165]

Wang et al. [174]

Fusion (%)

References

Table 4 continued

Outcomes

VAS decrease (%)

ODI decrease (%)

Outcome satisfaction (%)

Re-do (%)

Eur Spine J

lateral approaches. As such, an examination of those reports that used only traditional lateral approaches (traditional MI-LIF group) was compared to those reports that used either non-traditional lateral approaches or included patients treated with either traditional MI-LIF or non-traditional MI-LIF procedures (non-traditional MI-LIF group), where outcomes were not be separated between the groups. These literature cohorts were assessed through weighted averaging and results are included in Tables 5 and 6. In comparison to the primary outcomes related to the technique of the surgical procedures (complications and side effects), the traditional MI-LIF group showed an average new postoperative thigh sensory changes rate of 16.4 % in 1343 patients compared to 35.6 % in 1429 patients in the non-traditional MI-LIF group. Hip flexion weakness was similar between the traditional and nontraditional MI-LIF groups (20.9 vs. 20.7 %, respectively) while rates of new distal weaknesses were lower in the traditional MI-LIF group (1.6 vs. 5.1 %, respectively). Some reports did not separate out hip flexion and distal motor weakness, so when assessing all motor deficits (muscular and neural), the rate of occurrence in the traditional MI-LIF group was 12.1 % (1869 patients) compared to 22.1 % (1602 patients) in the non-traditional MI-LIF group. Of the studies that made up these results, higher quality evidence directly comparing perioperative outcomes between traditional MI-LIF and non-traditional MILIF was available and a large quantity of studies that were generally (though not completely) consistent with the quality findings lead to a moderate strength of conclusion that material differences exist between different MI-LIF approaches, with more favorable neural outcomes evident in traditional MI-LIF. Question 3—representative article Cheng et al. [124] directly compared perioperative adverse events, with an emphasis on neural and motor changes, between those patients treated with traditional MI-LIF, which included sequential dilation through the psoas muscle using evoked-EMG (XLIF) [2], and those treated using supra-psoas docking and directly visualized passage through the psoas muscle [shallow docking (SD)] at Stanford University Hospital [10]. In this, the authors analyzed 120 patients (70 traditional MI-LIF, 50 SD). Overall, the presence of new neurologic adverse events was higher in the SD group (24 %) compared to the traditional MI-LIF group (14.2 %) (p = 0.1751), and when examining neurologic outcomes in single level cases only (84/120), neurologic complications were almost three times more likely in the shallow docking compared to the traditional MI-LIF group (28.6 vs. 10.2 %, respectively) (p = 0.0302).

5781 (54)

7737 (67)

4869 (58)

2894 (22)

Mixed scoli (w degen/scoli)

Mixed degen (w degen/scoli)

Traditional lateral (XLIF) only

Non-traditional/mixed XLIF and non-XLIF lateral only

1179 (19)

970 (18)

1229 (8)

Mixed degen (w degen/ scoli)

Traditional lateral (XLIF) only

Non-traditional/ mixed XLIF and non-XLIF lateral only

20.5 % (0–54.9 %)

20.7 % (0–51.4 %)

20.9 % (0–54.9 %)

18.3 % (0–54.9 %)

21.1 % (1.2–54.9 %)

34 % (24–36 %)

14.7 % (0–23 %)

1568 (14)

390 (5)

1148 (9)

1515 (13)

864 (10)



651 (3)

2.6 % (0.0–9.5 %)

5.1 % (0–9.5 %)

1.6 % (0–6.7 %)

2.7 % (0–9.5 %)

3.9 % (0–9.5 %)



1.0 % (0–6.7 %)

3471 (35)

1602 (13)

1869 (22)

3311 (33)

2598 (25)



820 (9)

313.7 (136–910.7)

99.2 (26.5–230)

16.7 % (0–56.2 %) 4.2 % (0–23 %)

22.1 % (2.9–51.4 %)

12.1 % (0–56.2 %)

15.8 % (0–56.2 %)

20.3 % (0–56.2 %)



1114 (16)

910 (14) 292 (6)

198 (3)

1882 (21)

1966 (20)

869 (13)

114 (4)

1211

2080 (24)

n pts (n study arms)

263 (5)

1803 (26)

140.4 (26.5–910.7) 1774 (25)

164.1 (50–541)

78.7 (26.5–225) 227.5 (53–541)

7.0 % (1.7–10.1 %)

5.4 % (0–47 %)

5.3 % (0–47 %)

8.4 % (0–23 %)

10.6 % (4.3–23 %)

3.6 % (0.6–47 %)

214 (6)

2464 (31)

2398 (28)

1082 (21)

280 (9)

1596 (16)

27.3 % (0–43 %)

10.6 % (0–150 %)

10.2 % (0–43 %)

17.8 % (0–150 %)

27.5 % (0–150 %)

8.0 % (0–32 %)

12.0 % (0.0–150 %)

Total comps, % (range)

35.6 % (8.6–60.1 %)

16.4 % (0–75 %)

26.0 % (0–48.6 %)

28.8 %(1.2–75 %)

9.5 % (0–25 %) 33.1 % (12–75 %)

26.3 % (0–75 %)

Thigh SE, % (range)

2678 (37)

n pts (n study arms)

1429 (15)

1343 (25)

2602 (33)

2425 (30)

414 (11) 117 (6)

2772

n pts (n study arms)

5.6 % (0.0–47.0 %)

Reops, % (range)

6.9 (4–10)

2.5 (0.9–7.7)

2.7 (0.88–9.9)

3.9 (1.24–10)

1.6 (0.9–5.0) 5.2 (1.4–10)

3.0 (0.88–10)

LOS, days (range)

n number of patients or study arms with reported data and able to be calculated in the weighted average, f/u follow-up, ORT operating room time, EBL estimated blood loss, LOS length of postoperative hospital stay, SE side effects, HFW hip flexion weakness, reops reoperations, comps complications, VAS visual analog scale, ODI oswestry disability index, re-do patients indicated that they would have undergone the same procedure again if their outcome had been known in advance, Degen degenerative (non-deformity) spinal disease, Scoli scoliosis, degen/scoli mixed degenerative and scoliosis indications in the patient series, XLIF extreme lateral interbody fusion; traditional lateral (XLIF) only group: included reports that were of XLIF-lateral procedures only; non-traditional lateral (non-XLIF) only group: reports were included if they were either studies of non-XLIF lateral procedures or if there was a mixture of XLIF and non-XLIF lateral (e.g., shallow docking) procedures performed

128 (2)

2369 (23)

Mixed scoli (w degen/ scoli)

190 (7)

Degen

Scoliosis

1360 (22)

All studies

n pts (n study arms)

159.8 (26.5–910.7) 2066 (31)

EBL, mL (range)

All motor deficits (neural and HFW), % (range)

415 (8)

1054 (26)

1142 (26)

986 (20)

441 (13) 327 (8)

1469 (34)

n pts (n study arms)

n pts (n study arms)

262.2 (146–477)

143.2 (66–261)

198.9 (66–392)

225.8 (66–477)

113.5 (67–261) 223.1 (108–477)

202.5 (66–477)

ORT, mins (range)

Motor neural deficits, % (range)

1096 (14)

1104 (25)

1873 (31)

1639 (25)

519 (13) 327 (8)

2200 (39)

n pts (n study arms)

n pts (n study arms)

9.1 (1.5–40)

10.2 (1.5–36)

9.2 (1.5–36)

9.3 (1.5–40)

11.1 (1.5–36) 17.4 (1.5–40)

9.8 (1.5–40)

Mean f/u, months (range)

HFW, % (range)

1887 (24) 473 (12)

Degen Scoliosis

n pts (n study arms)

7763 (80)

All studies

n pts (n study arms)

Table 5 Weighted averages of study methods and side effect/complication outcomes from a systematic review of lateral transpsoas approach surgery, reported whole and in groups by surgical indication or procedure performed

Eur Spine J

123

123

106

615 (13)

801 (18)

856 (20)

Scoliosis

Mixed scoli (w degen/ scoli)

Mixed degen (w degen/ scoli)

Traditional lateral (XLIF) only 100 (100)

93.2 (80–100)

93.9 (85–100)

92.2 (80–100)

91.9 (80–100

96.7 (86.5–100)

93.6 (80–100)

Fusion, % (range)

129 (5)

1968 (36)

1919 (33)

1404 (25)

178 (8)

693 (16)

2097 (41)

n pts (n study arms)

58.8 (32.4–71)

60.0 (37–90)

60.1 (37–90)

56.4 (32.4–77.5)

57.9 (32–70)

67.1 (44.6–90)

60.0 (32.4–90)

VAS improvement, % (range)

64 (2)

1170 (27)

1099 (24)

921 (19)

135 (5)

313 (10)

1234 (29)

n pts (n study arms)

64.6 (51–52.1)

47.5 (21–89)

48.4 (31–89)

46.0 (21–82.1)

48.2 (21–82)

55.1 (31–89)

48.4 (21–89)

ODI improvement, % (range)



491 (9)

388 (7)

362 (7)

103 (2)

129 (2)

491 (9)

n pts (n study arms)



89.2 (84.8–100)

89.6 (84.8–95.5)

89.3 (84.8–100)

88 (85–100)

89 (89–89.4)

89.3 (84.8–100)

Outcome satisfaction, % (range)



334 (6)

231 (4)

205 (4)

103 (2)

129 (2)

334 (6)

n pts (n study arms)



85.0 (71–93)

85 (71–93)

81.1 (71–86)

85 (85–86)

91 (89.4–93)

85 (71–93)

Re-do, % (range)

n number of patients or study arms with reported data and able to be calculated in the weighted average, f/u follow-up, ORT operating room time, EBL estimated blood loss, LOS length of postoperative hospital stay, SE side effects, HFW hip flexion weakness, reops reoperations, comps complications, VAS visual analog scale, ODI oswestry disability index, re-do patients indicated that they would have undergone the same procedure again if their outcome had been known in advance, degen degenerative (non-deformity) spinal disease, scoli scoliosis, degen/scoli mixed degenerative and scoliosis indications in the patient series, XLIF extreme lateral interbody fusion; traditional lateral (XLIF) only group: included reports that were of XLIF-lateral procedures only, non-traditional lateral (non-XLIF) only group: reports were included if they were either studies of non-XLIF lateral procedures or if there was a mixture of XLIF and non-XLIF lateral (e.g., shallow docking) procedures performed

51 (2)

292 (9)

Degen

Non-traditional lateral (non-XLIF) only

907 (22)

All studies

n pts (n study arms)

Table 6 Weighted averages of clinical and radiographic outcomes from a systematic review of lateral transpsoas approach surgery, reported whole and in groups by surgical indication or procedure performed

Eur Spine J

Eur Spine J

Question 4: Are modern minimally disruptive procedures (e.g., MI-LIF) economically viable? There are only two articles which directly assess economics following MI-LIF [111, 160]. While they both represent higher quality studies (prospective registry data, comparative groups), they measure different variables and the authors of this work were, therefore, unable to assess consistency. Both manuscripts show significant cost savings using MI-LIF over conventional approaches during the perioperative period, measured through hospital operating costs or charges, but this low volume of work (quantity) with lack of comparability between (consistency) offsets their quality in assessing perioperative economics. Cost-effectiveness was assessed in neither, so only this limited economic scope can be considered. Due to these factors, there is low strength of evidence at this time to conclude that MI-LIF is an economically favorable approach to conventional approaches. Question 4—representative articles Two articles exist which describe the economics of MILIF. The first by Lucio et al. [111] compares clinical and economic outcomes of two-level minimally invasive (MIS) fusion (including XLIF in all patients at at least one level) with two-level open posterior lumbar interbody fusion (PLIF). Line-item actual hospital operating costs were examined to determine drivers of cost at different points within the perioperative period as well as the impact of performing procedures with similar surgical goals, through two different approaches. A total of 210 patients were included in the analysis (109 MIS and 101 open PLIF). Mean length of stay was 3.2 days for the open group and 1.2 days for the MIS group, and complications were significantly more frequent in the open group (14 vs. 6 %, respectively). Residual events (secondary medical interactions with the hospital outside of the acute perioperative period) were similarly more frequent in the open compared to MIS group (37 vs. 21 %). These clinical differences resulted in significant hospital operating cost savings, on average, of $2825 per patient (10.4 %), despite significantly higher up-front costs for MIS implants. A second study by Smith et al. [160] compared XLIF and anterior lumbar interbody fusion (ALIF) outcomes and economics and, similarly, found significantly fewer complications in the XLIF group which translated to 10 and 13.6 % cost savings (charges). At 2-year postoperative evaluation, outcomes between the two groups of patients were similar.

Discussion The purpose of this work was to compile and synthesize all currently available evidence on MI-LIF in an attempt to draw conclusions across four categories: (1) The anatomical justification for the approach, (2) an analysis of complication and outcome profiles following MI-LIF, (3) outcome variation between different lateral transpsoas approach procedures, and (4) an examination of current information regarding MIS economics. Question 1: Is there an anatomical justification for MI-LIF, particularly at L4–5? There is ongoing debate about the viability of the MI-LIF approach at the L4–5 level, primarily on location of the lumbar plexus with respect to the surgical corridor. This debate may be fueled by differences in MI-LIF systems and their respective trainings (e.g., integrated neuromonitoring), surgeon preference and comfort in adoption, and/or anecdotal reports perpetuating inconsistency. From a literature perspective, neural anatomy allows for a transpsoas approach to the lateral aspect of the spine from L1–2 through L4–5. A summary of the lateral approach anatomical literature by Smith et al. [30] was provided within an original examination of the effect of transitional anatomy at lower lumbar levels on the feasibility of the MI-LIF approach. In the literature review, when direct measurement studies were interpolated into zone categories (e.g., 75 % of anterior disc space free of motor nerves corresponded to zones I–III free of motor nerves), the authors found that there was broad agreement between the many high-quality studies available, finding that at least (and likely more when direct measurements instead of zones and soft-tissue retraction are considered), the anterior half of the lateral disc space is free of motor nerves. Those results are corroborated by the results in Table 1 in the current study. Additionally, while Moro et al. [250] separated the lateral disc space into quadrants to describe the location of relevant structures, the results of which have been replicated several times [19, 22, 24, 31], the results lack the specificity of the direct, finite measurements of many other anatomical studies of this region [16, 23, 25, 27, 28], where millimeters can make a difference in determining appropriate instrumentation dimensions. With respect to sensory nerves, the most relevant deep neural structure at risk is the genitofemoral nerve, which can generally be visually located as it emerges from the psoas muscle at the L3–4 disc space and it continues to travel inferiorly on the surface of the psoas muscle. A more posterior approach, anterior to motor nerves of the lumbar plexus, which can be monitored using electromyography

123

Eur Spine J

(EMG), largely reduces the risk of docking on the genitofemoral nerve. Additionally, several studies examined vascular structures on axial MRI, suggesting that the anterior portion of the accessible zone to the lateral disc space is sometimes covered by, most commonly, right-sided vessels [20, 24, 28]. While this is certainly worth consideration, vascular structures are generally much more mobile than neural structures, as shown by Deukmedjian et al. [21] who showed that vascular structures migrate anteriorly significantly when in vivo subjects are placed in the lateral decubitus position, suggesting that this apparent risk from cadaveric or supine MRI studies (where vessels likely fall dorsally) may be overstated. Regardless, there are sensitive structures on the lateral aspect of the spine anterior to the trunks and root of the lumbar plexus. These anterior structures (genitofemoral nerve and vasculature) are less able to be monitored, whereas posterior structures are using EMG. Anterior docking and posterior retraction of the psoas muscle risks injury to the genitofemoral nerve and vasculature, as well as the lumbar plexus as the requirement for dorsal expansion of the retractor to access the disc space can compress the substance of the psoas muscle, and embedded plexus into the transverse process. A more posterior targeting, active mapping of the neural elements with EMG, and ventral-only retractor expansion may both avoid injuries to the lumbar plexus through more objective intraoperative awareness and through avoidance of sensitive anterior structures [120]. While all surgical procedures carry risk of injury and complications, several MI-LIF case reports describe specific complications which, while rare, highlight the potential risk for such events. Examples include urological injury, coronal plane vertebral body fractures, cage overhang, cage migration, incisional hernia, contralateral nerve injury, psoas hematoma, seroma, and abscess (ipsilateral or contralateral), arterial pseudoaneurysm, bowel injury, and iliac or great vessel injury [56, 65, 68, 69, 72, 74, 82, 83, 85, 86, 89, 94, 126, 186]. For many of these potential risks, they highlight the need for a deep understanding of peritoneal, vascular, and neural anatomy combined with attention to preoperative axial MRI and diligent intraoperative technique. MI-LIF is a detail-oriented approach, and pairing expected anatomy with preoperative planning and intraoperative assessment of actual anatomy aids in complication avoidance. Question 2: What are the safety (complication) and outcome profiles of MI-LIF and are they acceptable in comparison with conventional approaches? Neural complications have long been considered the primary concern in MI-LIF. High-quality evidence supports,

123

overall, that MI-LIF has a complication profile superior to conventional interbody approaches and at least equivalent to alternative minimally disruptive approaches, on average [120] (Table 3). However, these data do not suggest that there is no risk of injury during these procedures. In fact, it is the contrary perspective. Given the anatomical understanding for the approach described in Tables 1 and 2, neural complication avoidance relies on preoperative planning paired with intraoperative adherence to neuromonitoring and diligent attention to technique. The issue of sensory changes and hip flexion weakness side effects postoperatively are artifacts of technique (position, extent, and duration of retraction), but also calls for the need for consistency in reporting and understanding within the literature [229, 247]. As far as the consideration, specifically, of designating mild transient hip flexion weakness and sensory changes as side effects, these authors believe it is analogous to back extension weakness and incisional pain (both of which are often more than mild) following open posterior fusion or PLIF. They are hardly, if ever, considered complications of the approach, as they are nearly universally encountered due to the exposure needed, but are real side effects that patients experience. It is within the understanding that all invasive medical interventions, by their nature, require access and some degree of effect based on that access that these and many other authors consider hip flexion weakness and mild, transient sensory changes to be common, expected, approach-related side effects, not complications of the approach. In assessing MI-LIF outcomes, there are many examples of mid- and long-term radiographic and clinical outcomes following MI-LIF [132–175], though with only one example of a direct comparison to conventional approaches, though that article is consistent with non-comparative findings and is at least equivalent to similar procedures (ALIF) at 2-year follow-up [160]. Question 3: Given technical and neuromonitoring differences between various MI-LIF procedures, are there any published clinical differences? The aggregate evidence shown here and early specific comparative reports of different approaches for MI-LIF suggest that these technical differences result in marked differences in outcome, specifically as they relate to neural complications and side effects [124] (Table 4). These differences manifest as elevated neural complication rates, on average, for non-traditional MI-LIF (e.g., those performed without specialized neurophysiologic monitoring, or any at all, those that advocate a more anterior passage through the psoas muscle, and/or those that advocate visual dissection through the psoas muscle to the lateral disc space) compared to traditional MI-LIF. As the procedure has regularly

Eur Spine J Table 7 Economics of MIS and open spine surgery

Instrumented fusion for spondylolisthesis

Exposure

2 yr $/QALY (k)

4 yr $/QALY (k)

SPORT results—Tosteson et al.

Open posterior

$116

$64

Rampersaud et al./Parker et al.

Open PLIF/TLIF

$109

$68

Rampersaud et al./Parker et al.

MIS PLIF/TLIF

$72

$38

yr year, QALY quality adjusted life year, SPORT spine patient outcomes research trial, PLIF posterior lumbar interbody fusion, MIS minimally invasive spine surgery, TLIF transforaminal lumbar interbody fusion, k number in thousands

been described as detail-oriented and passing adjacent to sensitive soft-tissue structures, it is not surprising that different outcomes have been realized following nuanced modifications to the described surgical procedure [2, 251]. This is not to advocate for one MI-LIF approach over another, but instead to put in context and describe differences between MI-LIF approaches with respect to literature validation and predicable and reproducible outcomes in a large body of evidence. Question 4: Is there currently evidence to support modern minimally disruptive approaches (including MI-LIF) from a cost-effectiveness perspective? Several studies of high-quality evidence exist describing the economics of spine surgery. Several large-scale prospective and/or randomized studies exist comparing surgical to non-surgical approaches [252, 253] as well as between MIS and conventional approaches [111, 160, 254, 255]. From a cost ($) per quality adjusted life year (QALY) ($/QALY) perspective, where $50 to $100 k per QALY for an intervention is considered ‘‘cost effective’’ in the US, several studies of conventional approaches for spinal fusion have been found to cost between $53.9 and $64.3 k per QALY [252, 253]. When considering MIS approaches, where complications often drive exponential increases in initial direct costs, there is a potential to substantially improve cost effectiveness should long-term clinical outcomes be at least equivalent, despite an up-front premium for MIS implants and instrumentation [111]. While there are several examples of MI-LIF economic analyses [111, 160], neither address long-term cost effectiveness. In other MIS approaches, direct cost-effectiveness comparisons with conventional approaches have been reported [254, 255]. These studies show a greater than 40 % improvement in cost effectiveness compared to conventional approaches (largely consistent with the previous conventional exposure cost effectiveness studies) through a 4-year postoperative assessment, and suggest the fulfillment of the promise of MIS approaches in general [230]. These reports, in their quality and corroboration with the MI-LIF economic reports, likely suggest low- to moderate-strength evidence favoring MIS economics, though additional studies are

needed. In the United States, where Medicare no longer pays for surgical site infections following spine surgery and penalties to hospitals are in place for hospital-acquired conditions, readmissions, and patient satisfaction, the economic viability of MIS approaches are even further supported at the local level, addressing a need for cost control and predictability for hospitals and hospital systems. An overview of open and MIS cost-effectiveness results is included in Table 7. In summary, these four MI-LIF topical areas—anatomy, outcomes, approach differences, and economics—have support within the literature from the 237 peer-reviewed papers that describe MI-LIF reviewed in this work. An anatomical justification for MI-LIF from L1–2 through L4–5 has many consistent examples of high-quality studies in corroboration. However, this anatomical justification should not be understood to obviate the need for diligent surgical technique and adherence to advanced neuromonitoring [247]. The principles of awareness of certain discoverable structures (plexus) and, conversely, to preoperative MRI assessment and intraoperative avoidance of less-easily discoverable structures (vasculature) are paramount to reproducibility, especially during the learning curve. Complication and clinical outcome findings are less consistent, but have a large body of evidence to support favorable findings on both counts within the context of current practice. These encompass the central tenets of MIS surgery compared to conventional approaches (improved morbidity with at least equivalence in outcome) and are moderately supported as true from the currently available literature. Next, emerging evidence supports that there are complication profile differences between different MI-LIF approaches and a thorough understanding of the literature is required to better understand these differences. Finally, and most importantly within the current healthcare environment, MIS and MI-LIF economic evidence and the resultant long-term implications are only recently emerging. What exists now is limited in scope, but these early reports support intuition—that benefits to patients in terms of decreased morbidity translates to surgical, hospital, and overall healthcare efficiency—and that such implications have the potential to echo between and support many parties involved in healthcare delivery.

123

Eur Spine J Acknowledgments The authors thank Kyle Malone, MS at NuVasive, Inc. for his statistical and editorial support. 18. Conflict of interest interest.

None of the authors has any potential conflict of

19.

References 1. Pimenta L (2001) Lateral endoscopic transpsoas retroperitoneal approach for lumbar spine surgery. Presented at VIII Brazilian Spine Society Meeting, Belo Horizonte 2. Ozgur BM, Aryan HE, Pimenta L, Taylor WR (2006) Extreme lateral interbody fusion (XLIF): a novel surgical technique for anterior lumbar interbody fusion. Spine J 4:435–443 3. Penta M, Fraser RD (1997) Anterior lumbar interbody fusion. A minimum 10-year follow-up. Spine 20:2429–2434 4. Rajaraman V, Vingan R, Roth P, Heary RF, Conklin L, Jacobs GB (1999) Visceral and vascular complications resulting from anterior lumbar interbody fusion. J Neurosurg 1(Suppl):60–64 5. Sasso RC, Kenneth BJ, LeHuec JC (2003) Retrograde ejaculation after anterior lumbar interbody fusion: transperitoneal versus retroperitoneal exposure. Spine 10:1023–1026 6. Wood KB, Devine J, Fischer D, Dettori JR, Janssen M (2010) Vascular injury in elective anterior lumbosacral surgery. Spine 9(Suppl):S66–S75 7. Okuda S, Miyauchi A, Oda T, Haku T, Yamamoto T, Iwasaki M (2006) Surgical complications of posterior lumbar interbody fusion with total facetectomy in 251 patients. J Neurosurg Spine 4:304–309 8. Rihn JA, Patel R, Makda J, Hong J, Anderson DG, Vaccaro AR, Hilibrand AS, Albert TJ (2009) Complications associated with single-level transforaminal lumbar interbody fusion. Spine J 8:623–629 9. Hardenbrook, MA, Miller, LE, Block, JE (2013) TranS1 VEO system: a novel psoas-sparing device for transpsoas lumbar interbody fusion. Med Devices (Auckl), pp 91–95 10. Acosta FL Jr, Drazin D, Liu JC (2013) Supra-psoas shallow docking in lateral interbody fusion. Neurosurgery 1(Suppl Operative):ons48–ons51 11. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O’Connell D, Oxman AD, Phillips B, Schunemann HJ, Edejer T, Varonen H, Vist GE, Williams JW Jr, Zaza S (2004) Grading quality of evidence and strength of recommendations. BMJ 7454:1490 12. Van Tulder M, Furlan A, Bombardier C, Bouter L (2003) Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine 12:1290–1299 13. Wright JG, Swiontkowski MF, Heckman JD (2003) Introducing levels of evidence to The Journal. J Bone Joint Surg 1:1–3 14. Dettori JR, Norvell DC, Dekutoski M, Fisher C, Chapman JR (2010) Methods for the systematic reviews on patient safety during spine surgery. Spine 9(Suppl):S22–S27 15. Banagan K, Gelb D, Poelstra K, Ludwig S (2011) Anatomic mapping of lumbar nerve roots during a direct lateral transpsoas approach to the spine: a cadaveric study. Spine 11:E687–E691 16. Benglis DM, Vanni S, Levi AD (2009) An anatomical study of the lumbosacral plexus as related to the minimally invasive transpsoas approach to the lumbar spine. J Neurosurg Spine 2:139–144 17. Dakwar E, Vale FL, Uribe JS (2011) Trajectory of the main sensory and motor branches of the lumbar plexus outside the

123

20.

21.

22.

23.

24.

25.

26.

27.

28.

29.

30.

31.

32.

33.

psoas muscle related to the lateral retroperitoneal transpsoas approach. J Neurosurg Spine 2:290–295 Dakwar E, Ahmadian A, Uribe JS (2012) The anatomical relationship of the diaphragm to the thoracolumbar junction during the minimally invasive lateral extracoelomic (retropleural/ retroperitoneal) approach. J Neurosurg Spine 4:359–364 Davis TT, Bae HW, Mok JM, Rasouli A, Delamarter RB (2011) Lumbar plexus anatomy within the psoas muscle: implications for the transpsoas lateral approach to the L4–L5 disc. J Bone Joint Surg Am 16:1482–1487 Delasotta LA, Radcliff K, Sonagli MA, Miller L (2012) Aberrant iliac artery: far lateral lumbosacral surgical anatomy. Orthopedics 2:e294–e297 Deukmedjian AR, Le TV, Dakwar E, Martinez CR, Uribe JS (2012) Movement of abdominal structures on magnetic resonance imaging during positioning changes related to lateral lumbar spine surgery: a morphometric study: clinical article. J Neurosurg Spine 6:615–623 Guerin P, Obeid I, Gille O, Bourghli A, Luc S, Pointillart V, Cursolle JC, Vital JM (2011) Safe working zones using the minimally invasive lateral retroperitoneal transpsoas approach: a morphometric study. Surg Radiol Anat 8:665–671 Guerin P, Obeid I, Bourghli A, Masquefa T, Luc S, Gille O, Pointillart V, Vital JM (2012) The lumbosacral plexus: anatomic considerations for minimally invasive retroperitoneal transpsoas approach. Surg Radiol Anat 2:151–157 Hu WK, He SS, Zhang SC, Liu YB, Li M, Hou TS, Ma XL, Wang J (2011) An MRI study of psoas major and abdominal large vessels with respect to the X/DLIF approach. Eur Spine J 4:557–562 Kepler CK, Bogner EA, Herzog RJ, Huang RC (2011) Anatomy of the psoas muscle and lumbar plexus with respect to the surgical approach for lateral transpsoas interbody fusion. Eur Spine J 4:550–556 Lu S, Chang S, Zhang YZ, Ding ZH, Xu XM, Xu YQ (2011) Clinical anatomy and 3D virtual reconstruction of the lumbar plexus with respect to lumbar surgery. BMC Musculoskelet Disord 12:76 Park DK, Lee MJ, Lin EL, Singh K, An HS, Phillips FM (2010) The relationship of intrapsoas nerves during a transpsoas approach to the lumbar spine: anatomic study. J Spinal Disord Tech 4:223–228 Regev GJ, Chen L, Dhawan M, Lee YP, Garfin SR, Kim CW (2009) Morphometric analysis of the ventral nerve roots and retroperitoneal vessels with respect to the minimally invasive lateral approach in normal and deformed spines. Spine 12:1330–1335 Shirzadi A, Birch K, Drazin D, Liu JC, Acosta F Jr (2012) Direct lateral interbody fusion (DLIF) at the lumbosacral junction L5– S1. J Clin Neurosci 7:1022–1025 Smith WD, Youssef JA, Christian G, Serrano S, Hyde JA (2012) Lumbarized sacrum as a relative contraindication for lateral transpsoas interbody fusion at L5–6. J Spinal Disord Tech 5:285–291 Uribe JS, Arredondo N, Dakwar E, Vale FL (2010) Defining the safe working zones using the minimally invasive lateral retroperitoneal transpsoas approach: an anatomical study. J Neurosurg Spine 2:260–266 Taher F, Hughes AP, Sama AA, Zeldin R, Schneider R, Holodny EI, Lebl DR, Fantini GA, Nguyen J, Cammisa FP, Girardi FP (2013) 2013 young investigator award winner: how safe is lateral lumbar interbody fusion for the surgeon? A prospective in vivo radiation exposure study. Spine 16:1386–1392 Baaj AA, Papadimitriou K, Amin AG, Kretzer RM, Wolinsky JP, Gokaslan ZL (2014) Surgical anatomy of the diaphragm in

Eur Spine J

34.

35.

36.

37.

38.

39.

40.

41.

42.

43.

44.

45.

46.

47.

48.

49.

the anterolateral approach to the spine: a cadaveric study. J Spinal Disord Tech 4:220–223 Menezes CM, de Andrade LM, da Silva Herrero CF, Defino HL, Ferreira Junior MA, Rodgers WB, Nogueira-Barbosa MH (2014) Diffusion-weighted magnetic resonance (DW-MR) neurography of the lumbar plexus in the preoperative planning of lateral access lumbar surgery. Eur Spine J [Epub ahead of print] Voyadzis JM, Felbaum D, Rhee J (2014) The rising psoas sign: an analysis of preoperative imaging characteristics of aborted minimally invasive lateral interbody fusions at L4-5. J Neurosurg Spine 5:531–537 Yusof MI, Nadarajan E, Abdullah MS (2014) The morphometric study of L3–L4 and L4–L5 lumbar spine in Asian population using magnetic resonance imaging: feasibility analysis for transpsoas lumbar interbody fusion. Spine 14:E811–E816 Cappuccino A, Cornwall GB, Turner AW, Fogel GR, Duong HT, Kim KD, Brodke DS (2010) Biomechanical analysis and review of lateral lumbar fusion constructs. Spine 26(Suppl):S361–S367 Fontes RB, Traynelis VC (2013) Iliac crest osteotomy to enhance exposure of the L4–5 interspace in minimally invasive lateral transpsoas interbody fusion: a cadaveric feasibility study. J Neurosurg Spine 1:13–17 Kretzer RM, Molina C, Hu N, Umekoji H, Baaj AA, Serhan H, Cunningham BW (2013) A comparative biomechanical analysis of stand alone versus facet screw and pedicle screw augmented lateral interbody arthrodesis: an in vitro human cadaveric model. J Spinal Disord Tech [Epub ahead of print] Laws CJ, Coughlin DG, Lotz JC, Serhan HA, Hu SS (2012) Direct lateral approach to lumbar fusion is a biomechanically equivalent alternative to the anterior approach: an in vitro study. Spine 10:819–825 Marulanda GA, Nayak A, Murtagh R, Santoni BG, Billys JB, Castellvi AE (2013) A cadaveric radiographic analysis on the effect of extreme lateral interbody fusion cage placement with supplementary internal fixation on indirect spine decompression. J Spinal Disord Tech [Epub ahead of print] Nayak AN, Gutierrez S, Billys JB, Santoni BG, Castellvi AE (2013) Biomechanics of lateral plate and pedicle screw constructs in lumbar spines instrumented at two levels with laterally placed interbody cages. Spine J 13:1331–1338 Pekmezci M, McDonald E, Kennedy A, Dedini R, McClellan T, Ames C, Deviren V (2012) Can a novel rectangular footplate provide higher resistance to subsidence than circular footplates? An ex vivo biomechanical study. Spine 19:E1177–E1181 Pimenta L, Turner AW, Dooley ZA, Parikh RD, Peterson MD (2012) Biomechanics of lateral interbody spacers: going wider for going stiffer. Sci World J 381814 Uribe JS, Smith DA, Dakwar E, Baaj AA, Mundis GM, Turner AW, Cornwall GB, Akbarnia BA (2012) Lordosis restoration after anterior longitudinal ligament release and placement of lateral hyperlordotic interbody cages during the minimally invasive lateral transpsoas approach: a radiographic study in cadavers. J Neurosurg Spine 5:476–485 Webb JE, Regev GJ, Garfin SR, Kim CW (2010) Navigationassisted fluoroscopy in minimally invasive direct lateral interbody fusion: a cadaveric study. SAS J 4:115–121 Deukmedjian AR, Manwaring J, Le TV, Turner AW, Uribe JS (2014) Corpectomy cage subsidence with rectangular versus round endcaps. J Clin Neurosci 9:1632–1636 Fogel GR, Parikh RD, Ryu SI, Turner AW (2014) Biomechanics of lateral lumbar interbody fusion constructs with lateral and posterior plate fixation: laboratory investigation. J Neurosurg Spine 3:291–297 Fogel GR, Turner AW, Dooley ZA, Cornwall GB (2014) Biomechanical stability of lateral interbody implants and

50.

51.

52.

53.

54.

55.

56.

57.

58.

59.

60. 61.

62.

63.

64.

65.

66.

67.

68.

supplemental fixation in a cadaveric degenerative spondylolisthesis model. Spine 19:E1138–E1146 O’Brien J, Haines C, Dooley ZA, Turner AW, Jackson D (2014) Femoral nerve strain at L4–L5 is minimized by hip flexion and increased by table break when performing lateral interbody fusion. Spine 1:33–38 Schreiber JJ, Hughes AP, Taher F, Girardi FP (2014) An association can be found between hounsfield units and success of lumbar spine fusion. HSS J 1:25–29 Straus D, Takagi I, O’Toole J (2015) Minimally invasive direct lateral approach to the thoracolumbar junction: cadaveric analysis and case illustrations. J Neurol Surg A Cent Eur Neurosurg 1:56–62 Tohmeh, AG, Isaacs, RE, Dooley, ZA, Turner, AWL (2015) Long construct pedicle screw reduction and residual forces are decreasing using a computer-assisted rod bending system. J Spine Neurosurg S2 Cheng WK, Jadhav V, Palmer DK (2011) A novel modification for removal of the polyethylene core in artificial disc retrieval using a transpsoas minimally invasive technique. J Neurosurg Spine 4:466–469 Pimenta L, Diaz RC, Guerrero LG (2006) Charite lumbar artificial disc retrieval: use of a lateral minimally invasive technique. Technical note. J Neurosurg Spine 6:556–561 Regev GJ, Haloman S, Chen L, Dhawan M, Lee YP, Garfin SR, Kim CW (2010) Incidence and prevention of intervertebral cage overhang with minimally invasive lateral approach fusions. Spine 14:1406–1411 Uribe JS, Dakwar E, Cardona RF, Vale FL (2011) Minimally invasive lateral retropleural thoracolumbar approach: cadaveric feasibility study and report of 4 clinical cases. Neurosurgery 1(Suppl Operative):32–39 Yson SC, Sembrano JN, Santos ER, Luna JT, Polly DW Jr (2014) Does prone re-positioning prior to posterior fixation produce greater lordosis in lateral lumbar interbody fusion (LLIF)? J Spinal Disord Tech 27:364–369 Aghayev K, Vrionis FD (2013) Mini-open lateral retroperitoneal lumbar spine approach using psoas muscle retraction technique. Technical report and initial results on six patients. Eur Spine J 9:2113–2119 Drazin D, Liu JC, Acosta FL Jr (2013) CT navigated lateral interbody fusion. J Clin Neurosci 10:1438–1441 Quante M, Halm H (2015) Extreme lateral interbody fusion : indication, surgical technique, outcomes and specific complications. Orthopade [Epub ahead of print] Adkins DE, Sandhu FA, Voyadzis JM (2013) Minimally invasive lateral approach to the thoracolumbar junction for corpectomy. J Clin Neurosci 20:1289–1294 Ahmadian A, Abel N, Uribe JS (2013) Functional recovery of severe obturator and femoral nerve injuries after lateral retroperitoneal transpsoas surgery. J Neurosurg Spine 4:409–414 Amin BY, Mummaneni PV, Ibrahim T, Zouzias A, Uribe J (2013) Four-level minimally invasive lateral interbody fusion for treatment of degenerative scoliosis. Neurosurg Focus 35:Video 10 Anand N, Baron EM (2013) Urological injury as a complication of the transpsoas approach for discectomy and interbody fusion. J Neurosurg Spine 1:18–23 Berjano P, Lamartina C (2011) Minimally invasive lateral transpsoas approach with advanced neurophysiologic monitoring for lumbar interbody fusion. Eur Spine J 9:1584–1586 Berjano P, Damilano M, Lamartina C (2012) Sagittal alignment correction and reconstruction of lumbar post-traumatic kyphosis via MIS lateral approach. Eur Spine J 12:2718–2720 Brier-Jones JE, Palmer DK, Inceoglu S, Cheng WK (2011) Vertebral body fractures after transpsoas interbody fusion procedures. Spine J 11:1068–1072

123

Eur Spine J 69. Daffner SD, Wang JC (2010) Migrated XLIF cage: case report and discussion of surgical technique. Orthopedics 7:518 70. Dakwar E, Smith WD, Malone KT, Uribe JS (2011) Minimally invasive lateral extracavitary resection of foraminal neurofibromas. J Clin Neurosci 11:1510–1512 71. Deukmedjian AR, Le TV, Baaj AA, Dakwar E, Smith DA, Uribe JS (2012) Anterior longitudinal ligament release using the minimally invasive lateral retroperitoneal transpsoas approach: a cadaveric feasibility study and report of 4 clinical cases. J Neurosurg Spine 6:530–539 72. Dua K, Kepler CK, Huang RC, Marchenko A (2010) Vertebral body fracture after anterolateral instrumentation and interbody fusion in two osteoporotic patients. Spine J 9:e11–e15 73. Eck JC (2011) Minimally invasive corpectomy and posterior stabilization for lumbar burst fracture. Spine J 9:904–908 74. Galan TV, Mohan V, Klineberg EO, Gupta MC, Roberto RF, Ellwitz JP (2012) Case report: incisional hernia as a complication of extreme lateral interbody fusion. Spine J 4:e1–e6 75. Ha KY, Kim YH, Seo JY, Bae SH (2013) Percutaneous posterior instrumentation followed by direct lateral interbody fusion for lumbar infectious spondylitis. J Spinal Disord Tech 3:E95–E100 76. Houten JK, Alexandre LC, Nasser R, Wollowick AL (2011) Nerve injury during the transpsoas approach for lumbar fusion. J Neurosurg Spine 3:280–284 77. Jahangiri FR, Sherman JH, Holmberg A, Louis R, Elias J, VegaBermudez F (2010) Protecting the genitofemoral nerve during direct/extreme lateral interbody fusion (DLIF/XLIF) procedures. Am J Electroneurodiagnostic Technol 4:321–335 78. Kanter AS, Gandhoke GS (2013) Lateral lumbar interbody fusion. Neurosurg Focus 35:Video 20 79. Keshavarzi S, Park MS, Aryan HE, Newman CB, Amene CS, Gonda D, Taylor WR (2009) Minimally invasive thoracic corpectomy and anterior fusion in a patient with metastatic disease: case report and review of the literature. Minim Invasive Neurosurg 3:141–143 80. Madhok R, Kanter AS (2010) Extreme-lateral, minimally invasive, transpsoas approach for the treatment of far-lateral lumbar disc herniation. J Neurosurg Spine 4:347–350 81. Massey GM, Caputo AM, Michael KW, Isaacs RE, Brown CR (2013) Lumbar facet cyst resolution following anterior interbody fusion. J Clin Neurosci 20:1771–1773 82. Murray MR, Weistroffer JK, Schafer MF (2012) Case report of an abscess developing at the site of a hematoma following a direct lateral interbody fusion. Spine J 7:e1–e4 83. Papanastassiou ID, Eleraky M, Vrionis FD (2011) Contralateral femoral nerve compression: an unrecognized complication after extreme lateral interbody fusion (XLIF). J Clin Neurosci 1:149–151 84. Petteys RJ, Sandhu FA (2013) Minimally invasive lateral retroperitoneal corpectomy for treatment of focal thoracolumbar kyphotic deformity: case report and review of the literature. J Neurol Surg A Cent Eur Neurosurg 75:305–309 85. Santillan A, Patsalides A, Gobin YP (2010) Endovascular embolization of iatrogenic lumbar artery pseudoaneurysm following extreme lateral interbody fusion (XLIF). Vasc Endovascular Surg 7:601–603 86. Taher F, Lebl DR, Hughes AP, Girardi FP (2013) Contralateral psoas seroma after transpsoas lumbar interbody fusion with bone morphogenetic protein-2 implantation. Spine J 2:e1–e5 87. Ahmadian A, Uribe JS (2013) Mini-open lateral retro-pleural thoracic corpectomy for osteomyelitis. Neurosurg Focus 35:Video 17 88. Amaral R, Marchi L, Oliveira L, Coutinho T, Pimenta L (2013) Acute lumbar burst fracture treated by minimally invasive lateral corpectomy. Case Rep Orthop 953897

123

89. Assina R, Majmundar NJ, Herschman Y, Heary RF (2014) First report of major vascular injury due to lateral transpsoas approach leading to fatality. J Neurosurg Spine 5:794–798 90. Hughes AP, Taher F, Farshad M, Aichmair A (2014) Multiple myeloma exacerbation following utilization of bone morphogenetic protein-2 in lateral lumbar interbody fusion: a case report and review of the literature. Spine J 4:e13–e19 91. Madhavan K, Vanni S, Williams SK (2014) Direct lateral retroperitoneal approach for the surgical treatment of lumbar discitis and osteomyelitis. Neurosurg Focus 2:E5 92. Malham GM (2014) Minimally invasive direct lateral corpectomy for the treatment of a thoracolumbar fracture. J Neurol Surg A Cent Eur Neurosurg [Epub ahead of print] 93. Morr S, Kanter AS (2013) Complex regional pain syndrome following lateral lumbar interbody fusion: case report. J Neurosurg Spine 4:502–506 94. Sandhu HK, Charlton-Ouw KM, Azizzadeh A, Estrera AL, Safi HJ (2013) Spinal screw penetration of the aorta. J Vasc Surg 6:1668–1670 95. Shepard M, Safain M, Burke SM, Hwang S, Kryzanski J, Riesenburger RI (2014) Lateral retroperitoneal transpsoas approach to the lumbar spine for the treatment of spondylodiscitis. Minim Invasive Ther Allied Technol 5:309–312 96. Staub BN, Holman PJ (2015) Lateral retroperitoneal transpsoas interbody fusion in a patient with achondroplastic dwarfism. J Neurosurg Spine 2:162–165 97. Tender GC, Serban D (2013) Genitofemoral nerve protection during the lateral retroperitoneal transpsoas approach. Neurosurgery 2 (Suppl Operative):ons192–ons196 98. Tender GC (2014) Caudal vertebral body fractures following lateral interbody fusion in non-osteoporotic patients. Ochsner J 1:123–130 99. Woodall MN, Shakir B, Smitherman A, Choudhri H (2013) Technical note: resolution of spontaneous electromyographic discharge following disk-space distraction during lateral transpsoas interbody fusion. Int J Spine Surg 7:e39–e41 100. Youssef JA, Orndorff DG, Scott MA, Ebner RE, Knewitz AP (2014) Sterile seroma resulting from multilevel XLIF procedure as possible adverse effect of prophylactic vancomycin powder: a case report. Evid Based Spine Care J 2:127–133 101. Aichmair A, Fantini GA, Garvin S, Beckman J, Girardi FP (2015) Aortic perforation during lateral lumbar interbody fusion. J Spinal Disord Tech 2:71–75 102. Cahill KS, Martinez JL, Wang MY, Vanni S, Levi AD (2012) Motor nerve injuries following the minimally invasive lateral transpsoas approach. J Neurosurg Spine 3:227–231 103. Cummock MD, Vanni S, Levi AD, Yu Y, Wang MY (2011) An analysis of postoperative thigh symptoms after minimally invasive transpsoas lumbar interbody fusion. J Neurosurg Spine 1:11–18 104. Dakwar E, Rifkin SI, Volcan IJ, Goodrich JA, Uribe JS (2011) Rhabdomyolysis and acute renal failure following minimally invasive spine surgery: report of 5 cases. J Neurosurg Spine 6:785–788 105. Dakwar E, Le TV, Baaj AA, Le AX, Smith WD, Akbarnia BA, Uribe JS (2011) Abdominal wall paresis as a complication of minimally invasive lateral transpsoas interbody fusion. Neurosurg Focus 4:E18 106. Knight RQ, Schwaegler P, Hanscom D, Roh J (2009) Direct lateral lumbar interbody fusion for degenerative conditions: early complication profile. J Spinal Disord Tech 1:34–37 107. Le TV, Baaj AA, Dakwar E, Burkett CJ, Murray G, Smith DA, Uribe JS (2012) Subsidence of polyetheretherketone intervertebral cages in minimally invasive lateral retroperitoneal transpsoas lumbar interbody fusion. Spine 14:1268–1273

Eur Spine J 108. Le TV, Smith DA, Greenberg MS, Dakwar E, Baaj AA, Uribe JS (2012) Complications of lateral plating in the minimally invasive lateral transpsoas approach. J Neurosurg Spine 3:302–307 109. Le TV, Burkett CJ, Deukmedjian AR, Uribe JS (2013) Postoperative lumbar plexus injury after lumbar retroperitoneal transpsoas minimally invasive lateral interbody fusion. Spine 1:E13–E20 110. Lee YP, Regev GJ, Chan J, Zhang B, Taylor W, Kim CW, Garfin SR (2013) Evaluation of hip flexion strength following lateral lumbar interbody fusion. Spine J 13:1259–1262 111. Lucio JC, VanConia RB, Deluzio KJ, Lehmen JA, Rodgers JA, Rodgers WB (2012) Economics of less invasive spinal surgery: an analysis of hospital cost differences between open and minimally invasive instrumented spinal fusion procedures during the perioperative period. Risk Manag Healthc Policy 5:65 112. Lykissas MG, Cho W, Aichmair A, Sama AA, Hughes AP, Lebl DR, Du JY, Cammisa FP, Girardi FP (2013) Is there any relation between the amount of curve correction and postoperative neurologic deficit or pain in patients undergoing standalone lateral lumbar interbody fusion? Spine 38:1656–1662 113. Marchi L, Abdala N, Oliveira L, Amaral R, Coutinho E, Pimenta L (2013) Radiographic and clinical evaluation of cage subsidence after stand-alone lateral interbody fusion. J Neurosurg Spine 1:110–118 114. Moller DJ, Slimack NP, Acosta FL Jr, Koski TR, Fessler RG, Liu JC (2011) Minimally invasive lateral lumbar interbody fusion and transpsoas approach-related morbidity. Neurosurg Focus 4:E4 115. Pumberger M, Hughes AP, Huang RR, Sama AA, Cammisa FP, Girardi FP (2012) Neurologic deficit following lateral lumbar interbody fusion. Eur Spine J 6:1192–1199 116. Rodgers WB, Cox CS, Gerber EJ (2010) Early complications of extreme lateral interbody fusion in the obese. J Spinal Disord Tech 6:393–397 117. Rodgers WB, Gerber EJ, Rodgers JA (2010) Lumbar fusion in octogenarians: the promise of minimally invasive surgery. Spine 26(Suppl):S355–S360 118. Rodgers WB, Gerber EJ, Patterson J (2011) Intraoperative and early postoperative complications in extreme lateral interbody fusion: an analysis of 600 cases. Spine 1:26–32 119. Sofianos DA, Briseno MR, Abrams J, Patel AA (2012) Complications of the lateral transpsoas approach for lumbar interbody arthrodesis: a case series and literature review. Clin Orthop Relat Res 6:1621–1632 120. Tohmeh AG, Rodgers WB, Peterson MD (2011) Dynamically evoked, discrete-threshold electromyography in the extreme lateral interbody fusion approach. J Neurosurg Spine 1:31–37 121. Aichmair A, Lykissas MG, Girardi FP, Sama AA, Lebl DR, Taher F, Cammisa FP, Hughes AP (2013) An institutional sixyear trend analysis of the neurological outcome after lateral lumbar interbody fusion: a 6-year trend analysis of a single institution. Spine 23:E1483–E1490 122. Al Maaieh MA, Du JY, Aichmair A, Huang RC, Hughes AP, Cammisa FP, Girardi FP, Sama AA (2014) Multivariate analysis on risk factors for postoperative ileus after lateral lumbar interbody fusion. Spine 8:688–694 123. Berjano P, Bassani R, Casero G, Sinigaglia A, Cecchinato R, Lamartina C (2013) Failures and revisions in surgery for sagittal imbalance: analysis of factors influencing failure. Eur Spine J 22:S853–S858 124. Cheng I, Briseno MR, Arrigo RT, Bains N, Ravi S, Tran A (2015) Outcomes of two different techniques using the lateral approach for lumbar interbody arthrodesis. Glob Spine J [Epub ahead of print]

125. Du JY, Aichmair A, Kueper J, Lam C, Nguyen JT, Cammisa FP, Lebl DR (2014) Incidental durotomy during spinal surgery: a multivariate analysis for risk factors. Spine 22:E1339–E1345 126. Kueper J, Fantini GA, Walker BR, Aichmair A, Hughes AP (2015) Incidence of vascular complications during lateral lumbar interbody fusion: an examination of the mini-open access technique. Eur Spine J [Epub ahead of print] 127. Lykissas MG, Aichmair A, Hughes AP, Sama AA, Lebl DR, Taher F, Du JY, Cammisa FP, Girardi FP (2014) Nerve injury after lateral lumbar interbody fusion: a review of 919 treated levels with identification of risk factors. Spine J 5:749–758 128. Lykissas MG, Aichmair A, Sama AA, Hughes AP, Lebl DR, Cammisa FP, Girardi FP (2014) Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study. Spine J 2:217–224 129. Nemani VM, Aichmair A, Taher F, Lebl DR, Hughes AP, Sama AA, Cammisa FP, Girardi FP (2014) Rate of revision surgery after stand-alone lateral lumbar interbody fusion for lumbar spinal stenosis. Spine 5:E326–E331 130. Taher F, Hughes AP, Lebl DR, Sama AA, Pumberger M, Aichmair A, Huang RC, Cammisa FP, Girardi FP (2013) Contralateral motor deficits after lateral lumbar interbody fusion. Spine 22:1959–1963 131. Uribe JS, Deukmedjian AR, Mummaneni PV, Fu KM, Mundis GM Jr, Okonkwo DO, Kanter AS, Eastlack R, Wang MY, Anand N, Fessler RG, La MF, Park P, Lafage V, Deviren V, Bess S, Shaffrey CI (2014) Complications in adult spinal deformity surgery: an analysis of minimally invasive, hybrid, and open surgical techniques. Neurosurg Focus 5:E15 132. Acosta FL, Liu J, Slimack N, Moller D, Fessler R, Koski T (2011) Changes in coronal and sagittal plane alignment following minimally invasive direct lateral interbody fusion for the treatment of degenerative lumbar disease in adults: a radiographic study. J Neurosurg Spine 1:92–96 133. Ahmadian A, Verma S, Mundis GM Jr, Oskouian RJ Jr, Smith DA, Uribe JS (2013) Minimally invasive lateral retroperitoneal transpsoas interbody fusion for L4–5 spondylolisthesis: clinical outcomes. J Neurosurg Spine 19:314–320 134. Benglis DM, Elhammady MS, Levi AD, Vanni S (2008) Minimally invasive anterolateral approaches for the treatment of back pain and adult degenerative deformity. Neurosurgery 3(Suppl):191–196 135. Berjano P, Balsano M, Buric J, Petruzzi M, Lamartina C (2012) Direct lateral access lumbar and thoracolumbar fusion: preliminary results. Eur Spine J 21:S37–S42 136. Elowitz EH, Yanni DS, Chwajol M, Starke RM, Perin NI (2011) Evaluation of indirect decompression of the lumbar spinal canal following minimally invasive lateral transpsoas interbody fusion: radiographic and outcome analysis. Minim Invasive Neurosurg 5–6:201–206 137. Hyde J, Seits M (2012) Clinical experience, outcomes, and learning curve following XLIF for lumbar degenerative conditions. World Spinal Column J 1:21–26 138. Johnson RD, Valore A, Villaminar A, Comisso M, Balsano M (2013) Pelvic parameters of sagittal balance in extreme lateral interbody fusion for degenerative lumbar disc disease. J Clin Neurosci 4:576–581 139. Karikari IO, Nimjee SM, Hardin CA, Hughes BD, Hodges TR, Mehta AI, Choi J, Brown CR, Isaacs RE (2011) Extreme lateral interbody fusion approach for isolated thoracic and thoracolumbar spine diseases: initial clinical experience and early outcomes. J Spinal Disord Tech 6:368–375 140. Kepler CK, Sharma AK, Huang RC (2011) Lateral transpsoas interbody fusion (LTIF) with plate fixation and unilateral

123

Eur Spine J

141.

142.

143.

144.

145.

146.

147.

148.

149.

150.

151.

152.

153.

154.

155.

156.

pedicle screws: a preliminary report. J Spinal Disord Tech 6:363–367 Kepler CK, Sharma AK, Huang RC, Meredith DS, Girardi FP, Cammisa FP Jr, Sama AA (2012) Indirect foraminal decompression after lateral transpsoas interbody fusion. J Neurosurg Spine 4:329–333 Kepler CK, Huang RC, Sharma AK, Meredith DS, Metitiri O, Sama AA, Girardi FP, Cammisa FP (2012) Factors influencing segmental lumbar lordosis after lateral transpsoas interbody fusion. Orthop Surg 2:71–75 Kotwal S, Kawaguchi S, Lebl D, Hughes A, Huang R, Sama A, Cammisa F, Girardi F (2012) Minimally invasive lateral lumbar interbody fusion: clinical and radiographic outcome at a minimum 2-year follow-up. J Spinal Disord Tech [Epub ahead of print] Le TV, Vivas AC, Dakwar E, Baaj AA, Uribe JS (2012) The effect of the retroperitoneal transpsoas minimally invasive lateral interbody fusion on segmental and regional lumbar lordosis. Sci World J 516706 Malham GM, Ellis NJ, Parker RM, Seex KA (2012) Clinical outcome and fusion rates after the first 30 extreme lateral interbody fusions. Sci World J 246989 Marchi L, Oliveira L, Amaral R, Castro C, Coutinho T, Coutinho E, Pimenta L (2012) Lateral interbody fusion for treatment of discogenic low back pain: minimally invasive surgical techniques. Adv Orthop 282068 Marchi L, Abdala N, Oliveira L, Amaral R, Coutinho E, Pimenta L (2012) Stand-alone lateral interbody fusion for the treatment of low-grade degenerative spondylolisthesis. Sci World J 456346 Nagineni VV, James AR, Alimi M, Hofstetter C, Shin BJ, Njoku I Jr, Tsiouris AJ, Hartl R (2012) Silicate-substituted calcium phosphate ceramic bone graft replacement for spinal fusion procedures. Spine 20:E1264–E1272 Oliveira L, Marchi L, Coutinho E, Abdala N, Pimenta L (2010) The use of rh-BMP2 in Standalone eXtreme lateral interbody fusion (XLIF): clinical and radiological results after 24 months follow-up. World Spinal Column J 1:19–25 Oliveira L, Marchi L, Coutinho E, Pimenta L (2010) A radiographic assessment of the ability of the extreme lateral interbody fusion procedure to indirectly decompress the neural elements. Spine 26(Suppl):S331–S337 Ozgur BM, Agarwal V, Nail E, Pimenta L (2010) Two-year clinical and radiographic success of minimally invasive lateral transpsoas approach for the treatment of degenerative lumbar conditions. SAS J 2:41–46 Pimenta L, Marchi L, Oliveira L, Coutinho E, Amaral R (2013) A prospective, randomized, controlled trial comparing radiographic and clinical outcomes between stand-alone lateral interbody lumbar fusion with either silicate calcium phosphate or rh-BMP2. J Neurol Surg A Cent Eur Neurosurg 76:343–350 Rodgers JA, Gerber EJ, Lehmen JA, Rodgers WB (2013) Clinical and radiographic outcome in less invasive lumbar fusion: XLIF at two year follow-up. J Spine Neurosurg 3:1–6 Rodgers WB, Cox CS, Gerber EJ (2007) Experience and early results with a minimally invasive technique for anterior column support through eXtreme Lateral Interbody Fusion (XLIF). US Musculoskelet Rev 28–32 Rodgers WB, Cox CS, Gerber EJ (2009) Minimally invasive treatment (XLIF) of adjacent segment disease after prior lumbar fusions. Internet J Minim Invasive Spinal Technol 3 Rodgers WB, Gerber EJ, Patterson JR (2010) Fusion after minimally disruptive anterior lumbar interbody fusion: analysis of extreme lateral interbody fusion by computed tomography. SAS J 2:63–66

123

157. Rodgers WB, Gerber EJ, Rodgers JA (2012) Clinical and radiographic outcomes of extreme lateral approach to interbody fusion with beta-tricalcium phosphate and hydroxyapatite composite for lumbar degenerative conditions. Int J Spine Surg 24–28 158. Rodgers WB, Lehmen JA, Gerber EJ, Rodgers JA (2012) Grade 2 spondylolisthesis at L4–5 treated by XLIF: safety and midterm results in the ‘‘worst case scenario’’. Sci World J 356712 159. Sharma AK, Kepler CK, Girardi FP, Cammisa FP, Huang RC, Sama AA (2011) Lateral lumbar interbody fusion: clinical and radiographic outcomes at 1 year: a preliminary report. J Spinal Disord Tech 4:242–250 160. Smith WD, Christian G, Serrano S, Malone KT (2012) A comparison of perioperative charges and outcome between open and mini-open approaches for anterior lumbar discectomy and fusion. J Clin Neurosci 5:673–680 161. Tohmeh AG, Watson B, Tohmeh M, Zielinski XJ (2012) Allograft cellular bone matrix in extreme lateral interbody fusion: preliminary radiographic and clinical outcomes. Sci World J 263637 162. Tohmeh AG, Khorsand D, Watson B, Zielinski X (2014) Radiographical and clinical evaluation of extreme lateral interbody fusion: effects of cage size and instrumentation type with a minimum of 1-year follow-up. Spine 26:E1582–E1591 163. Voyadzis JM, Anaizi AN (2013) Minimally invasive lumbar transfacet screw fixation in the lateral decubitus position after extreme lateral interbody fusion: a technique and feasibility study. J Spinal Disord Tech 2:98–106 164. Watkins RG, Hanna R, Chang D, Watkins RG III (2014) Sagittal alignment after lumbar interbody fusion: comparing anterior, lateral, and transforaminal approaches. J Spinal Disord Tech 27:253–256 165. Youssef JA, McAfee PC, Patty CA, Raley E, DeBauche S, Shucosky E, Chotikul L (2010) Minimally invasive surgery: lateral approach interbody fusion: results and review. Spine 26(Suppl):S302–S311 166. Ahmadian A, Bach K, Bolinger B, Malham GM, Okonkwo DO, Kanter AS, Uribe JS (2015) Stand-alone minimally invasive lateral lumbar interbody fusion: Multicenter clinical outcomes. J Clin Neurosci [Epub ahead of print] 167. Alimi M, Hofstetter CP, Cong GT, Tsiouris AJ, James AR, Paulo D, Elowitz E, Hartl R (2014) Radiological and clinical outcomes following extreme lateral interbody fusion. J Neurosurg Spine 6:623–635 168. Castellvi AE, Nienke TW, Marulanda GA, Murtagh RD, Santoni BG (2014) Indirect decompression of lumbar stenosis with transpsoas interbody cages and percutaneous posterior instrumentation. Clin Orthop Relat Res 6:1784–1791 169. Formica M, Berjano P, Cavagnaro L, Zanirato A, Piazzolla A, Formica C (2014) Extreme lateral approach to the spine in degenerative and post traumatic lumbar diseases: selection process, results and complications. Eur Spine J 684–692 170. Gates TA, Vasudevan RR, Miller KJ, Stamatopoulou V, Mindea SA (2014) A novel computer algorithm allows for volumetric and cross-sectional area analysis of indirect decompression following transpsoas lumbar arthrodesis despite variations in MRI technique. J Clin Neurosci 3:499–502 171. Malham GM, Parker RM, Goss B, Blecher CM, Ballok ZE (2014) Indirect foraminal decompression is independent of metabolically active facet arthropathy in extreme lateral interbody fusion. Spine 22:E1303–E1310 172. Oliveira DA, Fernandez JS, Falcon RS, Menezes CM (2014) Fusion via transpsoas lateral approach: considerations and initial results. Columna 3:214–218 173. Verla T, Adogwa O, Fatemi P, Martin JR, Gottfried ON, Cheng J, Isaacs RE (2015) Clinical implication of complications on

Eur Spine J

174.

175.

176.

177.

178.

179.

180.

181.

182.

183.

184.

185.

186.

187.

188.

189.

patient perceived health status following spinal fusion surgery. J Clin Neurosci 2:342–345 Wang MY, Vasudevan R, Mindea SA (2014) Minimally invasive lateral interbody fusion for the treatment of rostral adjacentsegment lumbar degenerative stenosis without supplemental pedicle screw fixation. J Neurosurg Spine 6:861–866 Akbarnia BA, Mundis GM Jr, Moazzaz P, Kabirian N, Bagheri R, Eastlack RK, Pawelek JB (2014) Anterior column realignment (ACR) For focal kyphotic spinal deformity using a lateral transpsoas approach and all release. J Spinal Disord Tech 27:29–39 Anand N, Baron EM, Thaiyananthan G, Khalsa K, Goldstein TB (2008) Minimally invasive multilevel percutaneous correction and fusion for adult lumbar degenerative scoliosis: a technique and feasibility study. J Spinal Disord Tech 7:459–467 Anand N, Rosemann R, Khalsa B, Baron EM (2010) Mid-term to long-term clinical and functional outcomes of minimally invasive correction and fusion for adults with scoliosis. Neurosurg Focus 3:E6 Anand N, Baron EM, Khandehroo B, Kahwaty S (2013) Long term 2 to 5 year clinical and functional outcomes of minimally invasive surgery (MIS) for adult scoliosis. Spine 38:1566–1575 Caputo AM, Michael KW, Chapman TM Jr., Massey GM, Howes CR, Isaacs RE, Brown CR (2012) Clinical outcomes of extreme lateral interbody fusion in the treatment of adult degenerative scoliosis. Sci World J 680643 Dakwar E, Cardona RF, Smith DA, Uribe JS (2010) Early outcomes and safety of the minimally invasive, lateral retroperitoneal transpsoas approach for adult degenerative scoliosis. Neurosurg Focus 3:E8 Deukmedjian AR, Dakwar E, Ahmadian A, Smith DA, Uribe JS (2012) Early outcomes of minimally invasive anterior longitudinal ligament release for correction of sagittal imbalance in patients with adult spinal deformity. Sci World J 789698 Isaacs RE, Hyde J, Goodrich JA, Rodgers WB, Phillips FM (2010) A prospective, nonrandomized, multicenter evaluation of extreme lateral interbody fusion for the treatment of adult degenerative scoliosis: perioperative outcomes and complications. Spine 26(Suppl):S322–S330 Marchi L, Oliveira L, Amaral R, Castro C, Coutinho T, Coutinho E, Pimenta L (2012) Anterior elongation as a minimally invasive alternative for sagittal imbalance-a case series. HSS J 2:122–127 McAfee PC, Shucosky E, Chotikul L, Salari B, Chen L, Jerrems D (2013) Multilevel extreme lateral interbody fusion (XLIF) and osteotomies for 3-dimensional severe deformity: 25 consecutive cases. Int J Spine Surg 7:e8–e19 Phillips FM, Isaacs RE, Rodgers WB, Khajavi K, Tohmeh AG, Deviren V, Peterson MD, Hyde J, Kurd M (2013) Adult degenerative scoliosis treated with XLIF: clinical and radiographic results of a prospective multi-center study with 24-month follow-up. Spine 38:1853–1861 Tormenti MJ, Maserati MB, Bonfield CM, Okonkwo DO, Kanter AS (2010) Complications and radiographic correction in adult scoliosis following combined transpsoas extreme lateral interbody fusion and posterior pedicle screw instrumentation. Neurosurg Focus 3:E7 Wang MY, Mummaneni PV (2010) Minimally invasive surgery for thoracolumbar spinal deformity: initial clinical experience with clinical and radiographic outcomes. Neurosurg Focus 3:E9 Berjano P, Aebi M (2015) Pedicle subtraction osteotomies (PSO) in the lumbar spine for sagittal deformities. Eur Spine J 49–57. doi:10.1007/s00586-014-3670-7 Caputo AM, Michael KW, Chapman TM, Jennings JM, Hubbard EW, Isaacs RE, Brown CR (2013) Extreme lateral

190.

191.

192.

193.

194.

195.

196.

197.

198. 199.

200.

201.

202.

203.

interbody fusion for the treatment of adult degenerative scoliosis. J Clin Neurosci 11:1558–1563 Castro C, Oliveira L, Amaral R, Marchi L, Pimenta L (2014) Is the lateral transpsoas approach feasible for the treatment of adult degenerative scoliosis? Clin Orthop Relat Res 6:1776–1783 Haque RM, Mundis GM Jr, Ahmed Y, El Ahmadieh TY, Wang MY, Mummaneni PV, Uribe JS, Okonkwo DO, Eastlack RK, Anand N, Kanter AS, La MF, Akbarnia BA, Park P, Lafage V, Terran JS, Shaffrey CI, Klineberg E, Deviren V, Fessler RG (2014) Comparison of radiographic results after minimally invasive, hybrid, and open surgery for adult spinal deformity: a multicenter study of 184 patients. Neurosurg Focus 5:E13 Khajavi K, Shen AY (2014) Two-year radiographic and clinical outcomes of a minimally invasive, lateral, transpsoas approach for anterior lumbar interbody fusion in the treatment of adult degenerative scoliosis. Eur Spine J 6:1215–1223 Manwaring JC, Bach K, Ahmadian AA, Deukmedjian AR, Smith DA, Uribe JS (2014) Management of sagittal balance in adult spinal deformity with minimally invasive anterolateral lumbar interbody fusion: a preliminary radiographic study. J Neurosurg Spine 5:515–522 Park P, Wang MY, Lafage V, Nguyen S, Ziewacz J, Okonkwo DO, Uribe JS, Eastlack RK, Anand N, Haque R, Fessler RG, Kanter AS, Deviren V, La MF, Smith JS, Shaffrey CI, Mundis GM Jr., Mummaneni PV (2015) Comparison of two minimally invasive surgery strategies to treat adult spinal deformity. J Neurosurg Spine [Epub ahead of print] Sciubba DM, Scheer JK, Yurter A, Smith JS, Lafage V, Klineberg E, Gupta M, Eastlack R, Mundis GM, Protopsaltis TS, Blaskiewicz D, Kim HJ, Koski T, Kebaish K, Shaffrey CI, Bess S, Hart RA, Schwab F, Ames CP (2015) Patients with spinal deformity over the age of 75: a retrospective analysis of operative versus non-operative management. Eur Spine J [Epub ahead of print] Tempel ZJ, Gandhoke GS, Bonfield CM, Okonkwo DO, Kanter AS (2014) Radiographic and clinical outcomes following combined lateral lumbar interbody fusion and posterior segmental stabilization in patients with adult degenerative scoliosis. Neurosurg Focus 5:E11 Wang MY, Mummaneni PV, Fu KM, Anand N, Okonkwo DO, Kanter AS, La MF, Fessler R, Uribe J, Shaffrey CI, Lafage V, Haque RM, Deviren V, Mundis GM Jr (2014) Less invasive surgery for treating adult spinal deformities: ceiling effects for deformity correction with 3 different techniques. Neurosurg Focus 5:E12 Anand N, Baron EM (2013) Minimally invasive approaches for the correction of adult spinal deformity. Eur Spine J 22:232–241 Bach K, Ahmadian A, Deukmedjian A, Uribe JS (2014) Minimally invasive surgical techniques in adult degenerative spinal deformity: a systematic review. Clin Orthop Relat Res 6:1749–1761 Banczerowski P, Czigleczki G, Papp Z, Veres R, Rappaport HZ, Vajda J (2015) Minimally invasive spine surgery: systematic review. Neurosurg Rev 1:11–26 Barbagallo GM, Albanese V, Raich AL, Dettori JR, Sherry N, Balsano M (2014) Lumbar lateral interbody fusion (LLIF): comparative effectiveness and safety versus PLIF/TLIF and predictive factors affecting LLIF Outcome. Evid Based Spine Care J 1:28–37 Barrey C, Darnis A (2015) Current strategies for the restoration of adequate lordosis during lumbar fusion. World J Orthop 1:117–126 Bina RW, Zoccali C, Skoch J, Baaj AA (2015) Surgical anatomy of the minimally invasive lateral lumbar approach. J Clin Neurosci 3:456–459

123

Eur Spine J 204. Costanzo G, Zoccali C, Maykowski P, Walter CM, Skoch J, Baaj AA (2014) The role of minimally invasive lateral lumbar interbody fusion in sagittal balance correction and spinal deformity. Eur Spine J 699–704. doi:10.1007/s00586-014-3561-y 205. Dahdaleh NS, Smith ZA, Snyder LA, Graham RB, Fessler RG, Koski TR (2014) Lateral transpsoas lumbar interbody fusion: outcomes and deformity correction. Neurosurg Clin N Am 2:353–360 206. Dangelmajer S, Zadnik PL, Rodriguez ST, Gokaslan ZL, Sciubba DM (2014) Minimally invasive spine surgery for adult degenerative lumbar scoliosis. Neurosurg Focus 5:E7 207. Graham RB, Wong AP, Liu JC (2014) Minimally invasive lateral transpsoas approach to the lumbar spine: pitfalls and complication avoidance. Neurosurg Clin N Am 2:219–231 208. He L, Dong J, Liu B, Chen R, Feng F, Rong L (2014) A MRI study of lumbar plexus in patients with degenerative lumbar scoliosis after extreme lateral interbody fusion. Zhonghua Yi Xue Za Zhi 3:178–181 209. Koreckij T, Park DK, Fischgrund J (2014) Minimally invasive spine surgery in the treatment of thoracolumbar and lumbar spine trauma. Neurosurg Focus 1:E11 210. Lykissas MG, Aichmair A (2013) Current concepts on spinal arthrodesis in degenerative disorders of the lumbar spine. World J Clin Cases 1:4–12 211. Mummaneni PV, Shaffrey CI, Lenke LG, Park P, Wang MY, La MF, Smith JS, Mundis GM Jr, Okonkwo DO, Moal B, Fessler RG, Anand N, Uribe JS, Kanter AS, Akbarnia B, Fu KM (2014) The minimally invasive spinal deformity surgery algorithm: a reproducible rational framework for decision making in minimally invasive spinal deformity surgery. Neurosurg Focus 5:E6 212. Omidi-Kashani F, Hasankhani EG, Ashjazadeh A (2014) Lumbar spinal stenosis: who should be fused? An updated review. Asian Spine J 4:521–530 213. Palejwala SK, Sheen WA, Walter CM, Dunn JH, Baaj AA (2014) Minimally invasive lateral transpsoas interbody fusion using a stand-alone construct for the treatment of adjacent segment disease of the lumbar spine: review of the literature and report of three cases. Clin Neurol Neurosurg 124:90–96 214. Park MS, Deukmedjian AR, Uribe JS (2014) Minimally invasive anterolateral corpectomy for spinal tumors. Neurosurg Clin N Am 2:317–325 215. Regan C, Kang JD (2013) The role of the minimally invasive extreme lateral interbody fusion procedure for complex spinal reconstruction. Oper tech Orthop 23:28–32 216. Skovrlj B, Gilligan J, Cutler HS, Qureshi SA (2015) Minimally invasive procedures on the lumbar spine. World J Clin Cases 1:1–9 217. Yoshihara H, Yoneoka D (2015) National trends in the surgical treatment for lumbar degenerative disc disease: United States, 2000 to 2009. Spine J 2:265–271 218. Baaj AA, Dakwar E, Le TV, Smith DA, Ramos E, Smith WD, Uribe JS (2012) Complications of the mini-open anterolateral approach to the thoracolumbar spine. J Clin Neurosci 9:1265–1267 219. Deviren V, Kuelling FA, Poulter G, Pekmezci M (2011) Minimal invasive anterolateral transthoracic transpleural approach: a novel technique for thoracic disc herniation. A review of the literature, description of a new surgical technique and experience with first 12 consecutive patients. J Spinal Disord Tech 5:E40–E48 220. Kasliwal MK, Deutsch H (2011) Minimally invasive retropleural approach for central thoracic disc herniation. Minim Invasive Neurosurg 4:167–171 221. Khan SN, Cha T, Hoskins JA, Pelton M, Singh K (2012) Minimally invasive thoracolumbar corpectomy and reconstruction. Orthopedics 1:e74–e79

123

222. Nacar OA, Ulu MO, Pekmezci M, Deviren V (2013) Surgical treatment of thoracic disc disease via minimally invasive lateral transthoracic trans/retropleural approach: analysis of 33 patients. Neurosurg Rev 3:455–465 223. Smith WD, Dakwar E, Le TV, Christian G, Serrano S, Uribe JS (2010) Minimally invasive surgery for traumatic spinal pathologies: a mini-open, lateral approach in the thoracic and lumbar spine. Spine 26(Suppl):S338–S346 224. Uribe JS, Dakwar E, Le TV, Christian G, Serrano S, Smith WD (2010) Minimally invasive surgery treatment for thoracic spine tumor removal: a mini-open, lateral approach. Spine 26(Suppl):S347–S354 225. Uribe JS, Smith WD, Pimenta L, Hartl R, Dakwar E, Modhia UM, Pollock GA, Nagineni V, Smith R, Christian G, Oliveira L, Marchi L, Deviren V (2012) Minimally invasive lateral approach for symptomatic thoracic disc herniation: initial multicenter clinical experience. J Neurosurg Spine 3:264–279 226. Berjano P, Garbossa D, Damilano M, Pejrona M, Bassani R, Doria C (2014) Transthoracic lateral retropleural minimally invasive microdiscectomy for T9-T10 disc herniation. Eur Spine J 6:1376–1378 227. Meredith DS, Kepler CK, Huang RC, Hegde VV (2013) Extreme lateral interbody fusion (XLIF) in the thoracic and thoracolumbar spine: technical report and early outcomes. HSS J 1:25–31 228. Acosta FL Jr, Aryan HE, Ames CP (2005) Emerging directions in motion preservation spinal surgery. Neurosurg Clin N Am 4:665–669 229. Ahmadian A, Deukmedjian AR, Abel N, Dakwar E, Uribe JS (2013) Analysis of lumbar plexopathies and nerve injury after lateral retroperitoneal transpsoas approach: diagnostic standardization. J Neurosurg Spine 3:289–297 230. Allen RT, Garfin SR (2010) The economics of minimally invasive spine surgery: the value perspective. Spine 26(Suppl):S375–S382 231. Arnold PM, Anderson KK, McGuire RA Jr (2012) The lateral transpsoas approach to the lumbar and thoracic spine: a review. Surg Neurol Int Suppl 3:S198–S215 232. Berjano P, Lamartina C (2013) Far lateral approaches (XLIF) in adult scoliosis. Eur Spine J S242–S253 233. Billinghurst J, Akbarnia BA (2009) Extreme lateral interbody fusion-XLIF. Curr Orthop Pract 3:238–251 234. Deukmedjian AR, Ahmadian A, Bach K, Zouzias A, Uribe JS (2013) Minimally invasive lateral approach for adult degenerative scoliosis: lessons learned. Neurosurg Focus 35:E4 235. Eck JC, Hodges S, Humphreys SC (2007) Minimally invasive lumbar spinal fusion. J Am Acad Orthop Surg 6:321–329 236. Falavigna A, Piccoli CL (2013) Minimally invasive approaches for thoracic decompression from discectomy to corpectomy. J Neurosurg Sci 3:175–192 237. Lall RR, Smith ZA, Wong AP, Miller D, Fessler RG (2012) Minimally invasive thoracic corpectomy: surgical strategies for malignancy, trauma, and complex spinal pathologies. Minim Invasive Surg 213791 238. Mummaneni PV, Tu TH, Ziewacz JE, Akinbo OC, Deviren V, Mundis GM (2013) The role of minimally invasive techniques in the treatment of adult spinal deformity. Neurosurg Clin N Am 2:231–248 239. Mundis GM, Akbarnia BA, Phillips FM (2010) Adult deformity correction through minimally invasive lateral approach techniques. Spine 26(Suppl):S312–S321 240. Nasca RJ (2013) Newer lumbar interbody fusion techniques. J Surg Orthop Adv 2:113–117 241. Oppenheimer JH, DeCastro I, McDonnell DE (2009) Minimally invasive spine technology and minimally invasive spine surgery: a historical review. Neurosurg Focus 3:E9

Eur Spine J 242. Patel AA, Brodke DS, Pimenta L, Bono CM, Hilibrand AS, Harrop JS, Riew KD, Youssef JA, Vaccaro AR (2008) Revision strategies in lumbar total disc arthroplasty. Spine 11:1276–1283 243. Patel VC, Park DK, Herkowitz HN (2012) Lateral transpsoas fusion: indications and outcomes. Sci World J 893608 244. Paulino C, Patel A, Carrer A (2010) Anatomical considerations for the extreme lateral (XLIF) approach. Curr Orthop Pract 4:368–374 245. Shen FH, Samartzis D, Khanna AJ, Anderson DG (2007) Minimally invasive techniques for lumbar interbody fusions. Orthop Clin North Am 3:373–386 246. Spoor AB, Oner FC (2013) Minimally invasive spine surgery in chronic low back pain patients. J Neurosurg Sci 3:203–218 247. Uribe JS, Vale FL, Dakwar E (2010) Electromyographic monitoring and its anatomical implications in minimally invasive spine surgery. Spine 26(Suppl):S368–S374 248. Wagner WH, Regan JJ, Leary SP, Lanman TH, Johnson JP, Rao RK, Cossman DV (2006) Access strategies for revision or explantation of the Charite lumbar artificial disc replacement. J Vasc Surg 6:1266–1272 249. Karikari IO, Grossi PM, Nimjee SM, Hardin C, Hodges TR, Hughes BD, Brown CR, Isaacs RE (2011) Minimally invasive lumbar interbody fusion in patients older than 70 years of age: analysis of peri- and postoperative complications. Neurosurgery 4:897–902 250. Moro T, Kikuchi S, Konno S, Yaginuma H (2003) An anatomic study of the lumbar plexus with respect to retroperitoneal endoscopic surgery. Spine 5:423–428

251. Peterson MD, Youssef JA (2013) Extreme lateral interbody fusion (XLIF): lumbar surgical technique. In: Goodrich JA, Volcan IJ (eds) Extreme lateral interbody fusion (XLIF). Quality Medical Publishing (QMP), St. Louis 252. Glassman SD, Polly DW, Dimar JR, Carreon LY (2012) The cost effectiveness of single-level instrumented posterolateral lumbar fusion at 5 years after surgery. Spine 9:769–774 253. Tosteson AN, Tosteson TD, Lurie JD, Abdu W, Herkowitz H, Andersson G, Albert T, Bridwell K, Zhao W, Grove MR, Weinstein MC, Weinstein JN (2011) Comparative effectiveness evidence from the spine patient outcomes research trial: surgical versus nonoperative care for spinal stenosis, degenerative spondylolisthesis, and intervertebral disc herniation. Spine 24:2061–2068 254. Parker SL, Adogwa O, Bydon A, Cheng J, McGirt MJ (2012) Cost-effectiveness of minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis associated low-back and leg pain over two years. World Neurosurg 1–2:178–184 255. Rampersaud YR, Gray R, Lewis SJ, Massicotte EM, Fehlings MG (2013) Cost-utility analysis of posterior minimally invasive fusion compared with conventional open fusion for lumbar spondylolisthesis. SAS J 5:29–35

123

MIS lateral spine surgery: a systematic literature review of complications, outcomes, and economics.

Over the past decade, the minimally disruptive lateral transpsoas approach for lumbar interbody fusion (MI-LIF) is increasingly being used as an alter...
408KB Sizes 5 Downloads 8 Views